CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: dihydrochalcones
Accession: CHEBI:71230
browse the term
Definition: Any ketone that is 1,3-diphenylpropanone and its derivatives obtained by substitution.
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 protein]
CTD
PMID:25338943
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Cxcl15
C-X-C motif chemokine ligand 15
multiple interactions
ISO
aspalathin inhibits the reaction [Glucose results in increased expression of CXCL8 mRNA]; aspalathin inhibits the reaction [Glucose results in increased expression of CXCL8 protein]
CTD
PMID:25338943
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
F10
coagulation factor X
multiple interactions
ISO
aspalathin inhibits the reaction [[F5 protein co-treated with F10 protein co-treated with Calcium Chloride] results in increased metabolism of F2 protein]; aspalathin inhibits the reaction [[TNF protein co-treated with F7 protein] results in increased expression of F10 protein]
CTD
PMID:25325928
NCBI chr 8:13,087,308...13,106,676
Ensembl chr 8:13,087,308...13,106,676
G
F2
coagulation factor II
multiple interactions
ISO
aspalathin inhibits the reaction [[F5 protein co-treated with F10 protein co-treated with Calcium Chloride] results in increased metabolism of F2 protein]
CTD
PMID:25325928
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F5
coagulation factor V
multiple interactions
ISO
aspalathin inhibits the reaction [[F5 protein co-treated with F10 protein co-treated with Calcium Chloride] results in increased metabolism of F2 protein]
CTD
PMID:25325928
NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
G
F7
coagulation factor VII
multiple interactions
ISO
aspalathin inhibits the reaction [[TNF protein co-treated with F7 protein] results in increased expression of F10 protein]
CTD
PMID:25325928
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
aspalathin inhibits the reaction [Glucose results in increased expression of ICAM1 protein]; aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ICAM1 mRNA]; aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ICAM1 protein]
CTD
PMID:25338943 PMID:25655391
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Il6
interleukin 6
multiple interactions
ISO
aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]
CTD
PMID:25655391
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions
ISO
aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]
CTD
PMID:25655391
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions
ISO
aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]
CTD
PMID:25655391
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
ISO
aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]
CTD
PMID:25655391
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
ISO
aspalathin inhibits the reaction [Glucose affects the localization of RELA protein]; aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of RELA protein]
CTD
PMID:25338943 PMID:25655391
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Sele
selectin, endothelial cell
multiple interactions
ISO
aspalathin inhibits the reaction [Glucose results in increased expression of SELE protein]; aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of SELE mRNA]; aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of SELE protein]
CTD
PMID:25338943 PMID:25655391
NCBI chr 1:163,867,200...163,886,056
Ensembl chr 1:163,875,773...163,885,246
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
multiple interactions
ISO
aspalathin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]
CTD
PMID:25325928
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TLR4 protein]
CTD
PMID:25655391
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
multiple interactions
ISO
aspalathin inhibits the reaction [[TNF protein co-treated with F7 protein] results in increased expression of F10 protein]; aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]; aspalathin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]
CTD
PMID:25325928 PMID:25655391
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
aspalathin inhibits the reaction [Glucose results in increased expression of VCAM1 protein]; aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of VCAM1 mRNA]; aspalathin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of VCAM1 protein]
CTD
PMID:25338943 PMID:25655391
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
1600012H06Rik
RIKEN cDNA 1600012H06 gene
decreases expression
ISO
avobenzone results in decreased expression of C6ORF120 mRNA
CTD
PMID:31016361
NCBI chr17:15,163,446...15,166,201
Ensembl chr17:15,163,446...15,179,832
G
Aadacl2
arylacetamide deacetylase like 2
decreases expression
ISO
avobenzone results in decreased expression of AADACL2 mRNA
CTD
PMID:31016361
NCBI chr 3:59,914,164...59,932,841
Ensembl chr 3:59,914,164...59,932,841
G
Aass
aminoadipate-semialdehyde synthase
increases expression
ISO
avobenzone results in increased expression of AASS mRNA
CTD
PMID:31016361
NCBI chr 6:23,072,172...23,132,985
Ensembl chr 6:23,072,172...23,132,985
G
Abca12
ATP-binding cassette, sub-family A member 12
decreases expression
ISO
avobenzone results in decreased expression of ABCA12 mRNA
CTD
PMID:31016361
NCBI chr 1:71,282,249...71,454,069
Ensembl chr 1:71,281,435...71,454,069
G
Abhd3
abhydrolase domain containing 3
increases expression
ISO
avobenzone results in increased expression of ABHD3 mRNA
CTD
PMID:31016361
NCBI chr18:10,644,411...10,706,784
Ensembl chr18:10,642,092...10,706,771
G
Acat2
acetyl-Coenzyme A acetyltransferase 2
increases expression
ISO
avobenzone results in increased expression of ACAT2 mRNA
CTD
PMID:31016361
NCBI chr17:13,161,929...13,179,612
Ensembl chr17:13,161,777...13,179,634
G
Acly
ATP citrate lyase
increases expression
ISO
avobenzone results in increased expression of ACLY mRNA
CTD
PMID:31016361
NCBI chr11:100,367,178...100,418,826
Ensembl chr11:100,367,179...100,418,826
G
Acss2
acyl-CoA synthetase short-chain family member 2
increases expression
ISO
avobenzone results in increased expression of ACSS2 mRNA
CTD
PMID:31016361
NCBI chr 2:155,359,963...155,404,663
Ensembl chr 2:155,359,868...155,427,644
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
increases expression
ISO
avobenzone results in increased expression of ADAMTS1 mRNA
CTD
PMID:31016361
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Adgre5
adhesion G protein-coupled receptor E5
increases expression
ISO
avobenzone results in increased expression of ADGRE5 mRNA
CTD
PMID:31016361
NCBI chr 8:84,449,874...84,467,812
Ensembl chr 8:84,449,880...84,467,955
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; T 0070907 affects the reaction [avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]
CTD
PMID:31016361 PMID:32407875
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Afap1
actin filament associated protein 1
increases expression
ISO
avobenzone results in increased expression of AFAP1 mRNA
CTD
PMID:31016361
NCBI chr 5:36,050,713...36,161,267
Ensembl chr 5:36,050,663...36,161,267
G
AI429214
expressed sequence AI429214
decreases expression
ISO
avobenzone results in decreased expression of C8ORF48 mRNA
CTD
PMID:31016361
NCBI chr 8:37,460,729...37,462,687
Ensembl chr 8:37,460,758...37,462,687
G
Aif1l
allograft inflammatory factor 1-like
decreases expression
ISO
avobenzone results in decreased expression of AIF1L mRNA
CTD
PMID:31016361
NCBI chr 2:31,840,315...31,863,454
Ensembl chr 2:31,840,151...31,863,454
G
Akr1c18
aldo-keto reductase family 1, member C18
increases expression
ISO
avobenzone results in increased expression of AKR1C3 mRNA
CTD
PMID:31016361
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
G
Akr1c20
aldo-keto reductase family 1, member C20
increases expression
ISO
avobenzone results in increased expression of AKR1C1 mRNA
CTD
PMID:31016361
NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344
G
Akr1c21
aldo-keto reductase family 1, member C21
increases expression
ISO
avobenzone results in increased expression of AKR1C2 mRNA
CTD
PMID:31016361
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
G
Aldh6a1
aldehyde dehydrogenase family 6, subfamily A1
increases expression
ISO
avobenzone results in increased expression of ALDH6A1 mRNA
CTD
PMID:31016361
NCBI chr12:84,477,491...84,497,798
Ensembl chr12:84,477,491...84,497,778
G
Ang
angiogenin, ribonuclease, RNase A family, 5
increases expression
ISO
avobenzone results in increased expression of ANG mRNA
CTD
PMID:31016361
NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466
G
Ank2
ankyrin 2, brain
decreases expression
ISO
avobenzone results in decreased expression of ANK2 mRNA
CTD
PMID:31016361
NCBI chr 3:126,715,256...127,293,996
Ensembl chr 3:126,715,261...127,292,999
G
Antxr1
anthrax toxin receptor 1
increases expression
ISO
avobenzone results in increased expression of ANTXR1 mRNA
CTD
PMID:31016361
NCBI chr 6:87,110,835...87,312,757
Ensembl chr 6:87,110,835...87,312,803
G
Aopep
aminopeptidase O
decreases expression
ISO
avobenzone results in decreased expression of AOPEP mRNA
CTD
PMID:31016361
NCBI chr13:63,112,707...63,473,910
Ensembl chr13:63,112,707...63,473,910
G
Ar
androgen receptor
affects binding multiple interactions
ISO
avobenzone binds to AR protein avobenzone binds to and results in decreased activity of AR protein
CTD
PMID:15537743 PMID:28115641
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Araf
Araf proto-oncogene, serine/threonine kinase
increases expression
ISO
avobenzone results in increased expression of ARAF mRNA
CTD
PMID:31016361
NCBI chr X:20,663,946...20,726,760
Ensembl chr X:20,664,053...20,726,758
G
Arhgap26
Rho GTPase activating protein 26
decreases expression
ISO
avobenzone results in decreased expression of ARHGAP26 mRNA
CTD
PMID:31016361
NCBI chr18:38,734,531...39,509,338
Ensembl chr18:39,126,198...39,509,337 Ensembl chr18:39,126,198...39,509,337
G
Arid3b
AT-rich interaction domain 3B
increases expression
ISO
avobenzone results in increased expression of ARID3B mRNA
CTD
PMID:31016361
NCBI chr 9:57,697,636...57,744,130
Ensembl chr 9:57,697,636...57,744,076
G
Asns
asparagine synthetase
decreases expression
ISO
avobenzone results in decreased expression of ASNS mRNA
CTD
PMID:31016361
NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
G
Asph
aspartate-beta-hydroxylase
increases expression
ISO
avobenzone results in increased expression of ASPH mRNA
CTD
PMID:31016361
NCBI chr 4:9,449,085...9,669,344
Ensembl chr 4:9,448,069...9,669,344
G
Asphd2
aspartate beta-hydroxylase domain containing 2
decreases expression
ISO
avobenzone results in decreased expression of ASPHD2 mRNA
CTD
PMID:31016361
NCBI chr 5:112,532,220...112,543,236
Ensembl chr 5:112,532,220...112,542,732
G
Ass1
argininosuccinate synthetase 1
decreases expression
ISO
avobenzone results in decreased expression of ASS1 mRNA
CTD
PMID:31016361
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
G
Atp10b
ATPase, class V, type 10B
decreases expression
ISO
avobenzone results in decreased expression of ATP10B mRNA
CTD
PMID:31016361
NCBI chr11:42,902,991...43,153,112
Ensembl chr11:43,040,704...43,153,112
G
Atp6v0d2
ATPase, H+ transporting, lysosomal V0 subunit D2
increases expression
ISO
avobenzone results in increased expression of ATP6V0D2 mRNA
CTD
PMID:31016361
NCBI chr 4:19,876,838...19,922,566
Ensembl chr 4:19,876,841...19,922,605
G
Bambi
BMP and activin membrane-bound inhibitor
decreases expression
ISO
avobenzone results in decreased expression of BAMBI mRNA
CTD
PMID:31016361
NCBI chr18:3,507,011...3,516,404
Ensembl chr18:3,507,923...3,516,404
G
Bbs12
Bardet-Biedl syndrome 12
decreases expression
ISO
avobenzone results in decreased expression of BBS12 mRNA
CTD
PMID:31016361
NCBI chr 3:37,366,695...37,383,334
Ensembl chr 3:37,366,703...37,375,602
G
Bcar3
breast cancer anti-estrogen resistance 3
increases expression
ISO
avobenzone results in increased expression of BCAR3 mRNA
CTD
PMID:31016361
NCBI chr 3:122,213,406...122,323,840
Ensembl chr 3:122,087,785...122,323,840
G
Bcdin3d
BCDIN3 domain containing
decreases expression
ISO
avobenzone results in decreased expression of BCDIN3D mRNA
CTD
PMID:31016361
NCBI chr15:99,367,965...99,372,611
Ensembl chr15:99,367,960...99,372,611
G
Bcl6b
B cell CLL/lymphoma 6, member B
decreases expression
ISO
avobenzone results in decreased expression of BCL6B mRNA
CTD
PMID:31016361
NCBI chr11:70,114,953...70,120,624
Ensembl chr11:70,114,954...70,120,624
G
Brd3os
bromodomain containing 3, opposite strand
decreases expression
ISO
avobenzone results in decreased expression of BRD3OS mRNA
CTD
PMID:31016361
NCBI chr 2:27,332,486...27,334,233
Ensembl chr 2:27,332,336...27,334,233
G
Btbd7
BTB domain containing 7
decreases expression multiple interactions
ISO
avobenzone results in decreased expression of BTBD7 mRNA avobenzone inhibits the reaction [IFI27 mRNA results in increased expression of BTBD7 mRNA]; IFI27 mRNA inhibits the reaction [avobenzone results in decreased expression of BTBD7 mRNA]
CTD
PMID:29981360
NCBI chr12:102,747,056...102,844,733
Ensembl chr12:102,747,056...102,844,730
G
Calhm6
calcium homeostasis modulator family member 6
increases expression
ISO
avobenzone results in increased expression of CALHM6 mRNA
CTD
PMID:31016361
NCBI chr10:34,002,063...34,003,968
Ensembl chr10:34,002,063...34,003,980
G
Calm4
calmodulin 4
decreases expression
ISO
avobenzone results in decreased expression of CALML5 mRNA
CTD
PMID:31016361
NCBI chr13:3,887,757...3,888,671
Ensembl chr13:3,887,757...3,888,673
G
Calr
calreticulin
increases expression
ISO
avobenzone results in increased expression of CALR mRNA
CTD
PMID:31016361
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
G
Camk1d
calcium/calmodulin-dependent protein kinase ID
decreases expression
ISO
avobenzone results in decreased expression of CAMK1D mRNA
CTD
PMID:31016361
NCBI chr 2:5,298,268...5,719,665
Ensembl chr 2:5,298,268...5,719,326
G
Cbs
cystathionine beta-synthase
decreases expression
ISO
avobenzone results in decreased expression of CBS mRNA
CTD
PMID:31016361
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
G
Ccbe1
collagen and calcium binding EGF domains 1
increases expression
ISO
avobenzone results in increased expression of CCBE1 mRNA
CTD
PMID:31016361
NCBI chr18:66,189,926...66,424,909
Ensembl chr18:66,178,373...66,435,812
G
Ccdc125
coiled-coil domain containing 125
decreases expression
ISO
avobenzone results in decreased expression of CCDC125 mRNA
CTD
PMID:31016361
NCBI chr13:100,805,442...100,833,748
Ensembl chr13:100,806,225...100,833,748
G
Ccdc167
coiled-coil domain containing 167
increases expression
ISO
avobenzone results in increased expression of CCDC167 mRNA
CTD
PMID:31016361
NCBI chr17:29,914,951...29,935,991
Ensembl chr17:29,906,331...29,936,018
G
Ccdc18
coiled-coil domain containing 18
decreases expression
ISO
avobenzone results in decreased expression of CCDC18 mRNA
CTD
PMID:31016361
NCBI chr 5:108,280,583...108,388,378
Ensembl chr 5:108,280,741...108,381,494
G
Ccdc71
coiled-coil domain containing 71
increases expression
ISO
avobenzone results in increased expression of CCDC71 mRNA
CTD
PMID:31016361
NCBI chr 9:108,329,701...108,343,145
Ensembl chr 9:108,337,726...108,343,137
G
Ccn1
cellular communication network factor 1
increases expression
ISO
avobenzone results in increased expression of CCN1 mRNA
CTD
PMID:31016361
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
G
Ccna1
cyclin A1
decreases expression
ISO
avobenzone results in decreased expression of CCNA1 mRNA
CTD
PMID:31016361
NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922
G
Ccng2
cyclin G2
increases expression
ISO
avobenzone results in increased expression of CCNG2 mRNA
CTD
PMID:31016361
NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090
G
Cdk19
cyclin dependent kinase 19
increases expression
ISO
avobenzone results in increased expression of CDK19 mRNA
CTD
PMID:31016361
NCBI chr10:40,225,283...40,359,814
Ensembl chr10:40,215,560...40,359,814
G
Cdkn2aipnl
CDKN2A interacting protein N-terminal like
increases expression
ISO
avobenzone results in increased expression of CDKN2AIPNL mRNA
CTD
PMID:31016361
NCBI chr11:51,858,458...51,868,163
Ensembl chr11:51,858,488...51,868,161
G
Cdkn2b
cyclin dependent kinase inhibitor 2B
decreases expression
ISO
avobenzone results in decreased expression of CDKN2B mRNA
CTD
PMID:31016361
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
G
Cdkn2d
cyclin dependent kinase inhibitor 2D
increases expression
ISO
avobenzone results in increased expression of CDKN2D mRNA
CTD
PMID:31016361
NCBI chr 9:21,199,759...21,202,553
Ensembl chr 9:21,199,706...21,202,703
G
Cebpa
CCAAT/enhancer binding protein alpha
decreases expression
ISO
avobenzone results in decreased expression of CEBPA mRNA
CTD
PMID:31016361
NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
G
Cenpe
centromere protein E
decreases expression
ISO
avobenzone results in decreased expression of CENPE mRNA
CTD
PMID:31016361
NCBI chr 3:134,918,324...134,979,301
Ensembl chr 3:134,918,298...134,979,372
G
Cep104
centrosomal protein 104
increases expression
ISO
avobenzone results in increased expression of CEP104 mRNA
CTD
PMID:31016361
NCBI chr 4:154,059,649...154,093,189
Ensembl chr 4:154,059,651...154,093,189
G
Ces1d
carboxylesterase 1D
increases expression
ISO
avobenzone results in increased expression of CES1 mRNA
CTD
PMID:31016361
NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466
G
Cfap70
cilia and flagella associated protein 70
decreases expression
ISO
avobenzone results in decreased expression of CFAP70 mRNA
CTD
PMID:31016361
NCBI chr14:20,444,258...20,502,332
Ensembl chr14:20,444,261...20,502,294
G
Chac1
ChaC, cation transport regulator 1
decreases expression
ISO
avobenzone results in decreased expression of CHAC1 mRNA
CTD
PMID:31016361
NCBI chr 2:119,181,723...119,184,807
Ensembl chr 2:119,181,710...119,184,862
G
Chac2
ChaC, cation transport regulator 2
decreases expression
ISO
avobenzone results in decreased expression of CHAC2 mRNA
CTD
PMID:31016361
NCBI chr11:30,926,707...30,936,365
Ensembl chr11:30,926,707...30,936,350
G
Chml
choroideremia-like
decreases expression
ISO
avobenzone results in decreased expression of CHML mRNA
CTD
PMID:31016361
NCBI chr 1:175,509,803...175,520,198
Ensembl chr 1:175,509,803...175,520,467
G
Cited4
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
increases expression
ISO
avobenzone results in increased expression of CITED4 mRNA
CTD
PMID:31016361
NCBI chr 4:120,523,760...120,525,017
Ensembl chr 4:120,523,769...120,525,017
G
Cldn19
claudin 19
decreases expression
ISO
avobenzone results in decreased expression of CLDN19 mRNA
CTD
PMID:31016361
NCBI chr 4:119,112,638...119,119,635
Ensembl chr 4:119,112,611...119,119,635
G
Clhc1
clathrin heavy chain linker domain containing 1
decreases expression
ISO
avobenzone results in decreased expression of CLHC1 mRNA
CTD
PMID:31016361
NCBI chr11:29,497,950...29,528,360
Ensembl chr11:29,497,950...29,528,367
G
Clip2
CAP-GLY domain containing linker protein 2
increases expression
ISO
avobenzone results in increased expression of CLIP2 mRNA
CTD
PMID:31016361
NCBI chr 5:134,518,237...134,582,922
Ensembl chr 5:134,518,237...134,581,288
G
Clk3
CDC-like kinase 3
increases expression
ISO
avobenzone results in increased expression of CLK3 mRNA
CTD
PMID:31016361
NCBI chr 9:57,657,904...57,672,397
Ensembl chr 9:57,657,907...57,673,143
G
Cmklr2
chemerin chemokine-like receptor 2
decreases expression
ISO
avobenzone results in decreased expression of CMKLR2 mRNA
CTD
PMID:31016361
NCBI chr 1:63,221,737...63,253,714
Ensembl chr 1:63,221,850...63,253,702
G
Cmtm7
CKLF-like MARVEL transmembrane domain containing 7
increases expression
ISO
avobenzone results in increased expression of CMTM7 mRNA
CTD
PMID:31016361
NCBI chr 9:114,585,904...114,611,061
Ensembl chr 9:114,585,904...114,610,924
G
Cnpy3
canopy FGF signaling regulator 3
increases expression
ISO
avobenzone results in increased expression of CNPY3 mRNA
CTD
PMID:31016361
NCBI chr17:47,046,637...47,063,639
Ensembl chr17:47,046,631...47,063,140
G
Cnst
consortin, connexin sorting protein
increases expression
ISO
avobenzone results in increased expression of CNST mRNA
CTD
PMID:31016361
NCBI chr 1:179,374,009...179,455,043
Ensembl chr 1:179,373,935...179,455,043
G
Cox19
cytochrome c oxidase assembly protein 19
decreases expression
ISO
avobenzone results in decreased expression of COX19 mRNA
CTD
PMID:31016361
NCBI chr 5:139,323,577...139,330,921
Ensembl chr 5:139,321,944...139,337,173
G
Crebrf
CREB3 regulatory factor
increases expression
ISO
avobenzone results in increased expression of CREBRF mRNA
CTD
PMID:31016361
NCBI chr17:26,918,716...26,995,611
Ensembl chr17:26,934,624...26,995,609
G
Creg2
cellular repressor of E1A-stimulated genes 2
increases expression
ISO
avobenzone results in increased expression of CREG2 mRNA
CTD
PMID:31016361
NCBI chr 1:39,657,574...39,690,350
Ensembl chr 1:39,657,574...39,690,642
G
Cutal
cutA divalent cation tolerance homolog-like
decreases expression
ISO
avobenzone results in decreased expression of CUTALP mRNA
CTD
PMID:31016361
NCBI chr 2:34,764,408...34,782,145
Ensembl chr 2:34,764,408...34,782,144
G
Cxcl15
C-X-C motif chemokine ligand 15
increases expression
ISO
avobenzone results in increased expression of CXCL8 protein
CTD
PMID:25617811
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
avobenzone results in increased expression of CYP1A1 mRNA
CTD
PMID:31016361
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases expression
ISO
avobenzone results in decreased expression of CYP1B1 mRNA
CTD
PMID:31016361
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Cyp4f14
cytochrome P450, family 4, subfamily f, polypeptide 14
decreases expression
ISO
avobenzone results in decreased expression of CYP4F12 mRNA
CTD
PMID:31016361
NCBI chr17:33,122,331...33,136,353
Ensembl chr17:33,124,044...33,136,316
G
Dbp
D site albumin promoter binding protein
increases expression
ISO
avobenzone results in increased expression of DBP mRNA
CTD
PMID:31016361
NCBI chr 7:45,354,658...45,359,579
Ensembl chr 7:45,354,512...45,359,627
G
Dcbld2
discoidin, CUB and LCCL domain containing 2
increases expression
ISO
avobenzone results in increased expression of DCBLD2 mRNA
CTD
PMID:31016361
NCBI chr16:58,228,789...58,304,013
Ensembl chr16:58,228,806...58,290,090
G
Ddx54
DEAD box helicase 54
increases expression
ISO
avobenzone results in increased expression of DDX54 mRNA
CTD
PMID:31016361
NCBI chr 5:120,751,182...120,766,657
Ensembl chr 5:120,750,804...120,766,657
G
Ddx59
DEAD box helicase 59
increases expression
ISO
avobenzone results in increased expression of DDX59 mRNA
CTD
PMID:31016361
NCBI chr 1:136,343,009...136,384,019
Ensembl chr 1:136,343,009...136,367,896
G
Decr2
2-4-dienoyl-Coenzyme A reductase 2, peroxisomal
decreases expression
ISO
avobenzone results in decreased expression of DECR2 mRNA
CTD
PMID:31016361
NCBI chr17:26,300,182...26,309,096
Ensembl chr17:26,300,182...26,309,311
G
Dennd5b
DENN domain containing 5B
increases expression
ISO
avobenzone results in increased expression of DENND5B mRNA
CTD
PMID:31016361
NCBI chr 6:148,889,566...149,003,178
Ensembl chr 6:148,889,569...149,003,178
G
Dgat2
diacylglycerol O-acyltransferase 2
decreases expression
ISO
avobenzone results in decreased expression of DGAT2 mRNA
CTD
PMID:31016361
NCBI chr 7:98,802,870...98,831,920
Ensembl chr 7:98,802,865...98,831,926
G
Dhcr7
7-dehydrocholesterol reductase
increases expression
ISO
avobenzone results in increased expression of DHCR7 mRNA
CTD
PMID:31016361
NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147
G
Dhrs9
dehydrogenase/reductase 9
decreases expression
ISO
avobenzone results in decreased expression of DHRS9 mRNA
CTD
PMID:31016361
NCBI chr 2:69,210,806...69,233,430
Ensembl chr 2:69,210,789...69,234,877
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
increases expression
ISO
avobenzone results in increased expression of DKK1 mRNA
CTD
PMID:31016361
NCBI chr19:30,523,276...30,526,896
Ensembl chr19:30,523,263...30,527,065
G
Dkk3
dickkopf WNT signaling pathway inhibitor 3
increases expression
ISO
avobenzone results in increased expression of DKK3 mRNA
CTD
PMID:31016361
NCBI chr 7:111,715,226...111,758,689
Ensembl chr 7:111,715,224...111,758,264
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
ISO
avobenzone results in increased expression of DNAJB9 mRNA
CTD
PMID:31016361
NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
G
Dnajc30
DnaJ heat shock protein family (Hsp40) member C30
decreases expression
ISO
avobenzone results in decreased expression of DNAJC30 mRNA
CTD
PMID:31016361
NCBI chr 5:135,093,060...135,094,219
Ensembl chr 5:135,093,056...135,094,716
G
Dok7
docking protein 7
increases expression
ISO
avobenzone results in increased expression of DOK7 mRNA
CTD
PMID:31016361
NCBI chr 5:35,213,922...35,245,183
Ensembl chr 5:35,214,110...35,245,183
G
Dsc1
desmocollin 1
decreases expression
ISO
avobenzone results in decreased expression of DSC1 mRNA
CTD
PMID:31016361
NCBI chr18:20,216,528...20,247,830
Ensembl chr18:20,217,241...20,247,928
G
Dsg1a
desmoglein 1 alpha
decreases expression
ISO
avobenzone results in decreased expression of DSG1 mRNA
CTD
PMID:31016361
NCBI chr18:20,443,982...20,476,407
Ensembl chr18:20,443,868...20,476,407
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
avobenzone results in increased expression of DUSP10 mRNA
CTD
PMID:31016361
NCBI chr 1:183,766,575...183,807,833
Ensembl chr 1:183,745,499...183,807,833
G
Dusp4
dual specificity phosphatase 4
increases expression
ISO
avobenzone results in increased expression of DUSP4 mRNA
CTD
PMID:31016361
NCBI chr 8:35,274,448...35,289,106
Ensembl chr 8:35,274,451...35,287,048
G
Ebp
EBP cholestenol delta-isomerase
increases expression
ISO
avobenzone results in increased expression of EBP mRNA
CTD
PMID:31016361
NCBI chr X:8,051,568...8,059,751
Ensembl chr X:8,051,568...8,059,751
G
Echdc3
enoyl Coenzyme A hydratase domain containing 3
increases expression
ISO
avobenzone results in increased expression of ECHDC3 mRNA
CTD
PMID:31016361
NCBI chr 2:6,193,276...6,217,805
Ensembl chr 2:6,193,276...6,217,844
G
Ecm2
extracellular matrix protein 2, female organ and adipocyte specific
decreases expression
ISO
avobenzone results in decreased expression of ECM2 mRNA
CTD
PMID:31016361
NCBI chr13:49,658,259...49,686,267
Ensembl chr13:49,658,286...49,686,265
G
Egfr
epidermal growth factor receptor
increases expression
ISO
avobenzone results in increased expression of EGFR mRNA
CTD
PMID:31016361
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Eid2
EP300 interacting inhibitor of differentiation 2
decreases expression
ISO
avobenzone results in decreased expression of EID2 mRNA
CTD
PMID:31016361
NCBI chr 7:27,967,306...27,968,593
Ensembl chr 7:27,967,306...27,968,697
G
Eif2ak4
eukaryotic translation initiation factor 2 alpha kinase 4
increases expression
ISO
avobenzone results in increased expression of EIF2AK4 mRNA
CTD
PMID:31016361
NCBI chr 2:118,219,065...118,305,715
Ensembl chr 2:118,219,099...118,305,715
G
Elp1
elongator complex protein 1
increases expression
ISO
avobenzone results in increased expression of ELP1 mRNA
CTD
PMID:31016361
NCBI chr 4:56,746,547...56,802,565
Ensembl chr 4:56,749,680...56,802,331
G
Emp3
epithelial membrane protein 3
increases expression
ISO
avobenzone results in increased expression of EMP3 mRNA
CTD
PMID:31016361
NCBI chr 7:45,567,447...45,570,850
Ensembl chr 7:45,567,447...45,570,828
G
Epha4
Eph receptor A4
decreases expression
ISO
avobenzone results in decreased expression of EPHA4 mRNA
CTD
PMID:31016361
NCBI chr 1:77,343,819...77,491,763
Ensembl chr 1:77,343,822...77,491,725
G
Ephx3
epoxide hydrolase 3
decreases expression
ISO
avobenzone results in decreased expression of EPHX3 mRNA
CTD
PMID:31016361
NCBI chr17:32,402,742...32,408,444
Ensembl chr17:32,402,744...32,408,523
G
Epm2aip1
EPM2A interacting protein 1
decreases expression
ISO
avobenzone results in decreased expression of EPM2AIP1 mRNA
CTD
PMID:31016361
NCBI chr 9:111,100,913...111,108,161
Ensembl chr 9:111,100,997...111,108,161
G
Eri1
exoribonuclease 1
increases expression
ISO
avobenzone results in increased expression of ERI1 mRNA
CTD
PMID:31016361
NCBI chr 8:35,932,419...35,962,687
Ensembl chr 8:35,932,407...35,963,350
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
avobenzone binds to and results in increased activity of ESR1 protein
CTD
PMID:15537743
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Etv4
ets variant 4
increases expression
ISO
avobenzone results in increased expression of ETV4 mRNA
CTD
PMID:31016361
NCBI chr11:101,660,573...101,677,963
Ensembl chr11:101,660,568...101,676,197
G
F2r
coagulation factor II thrombin receptor
increases expression
ISO
avobenzone results in increased expression of F2R mRNA
CTD
PMID:31016361
NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995
G
Fabp4
fatty acid binding protein 4, adipocyte
multiple interactions
ISO
avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]
CTD
PMID:31016361 PMID:32407875
NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636
G
Fam185a
family with sequence similarity 185, member A
decreases expression
ISO
avobenzone results in decreased expression of FAM185A mRNA
CTD
PMID:31016361
NCBI chr 5:21,629,861...21,693,269
Ensembl chr 5:21,629,956...21,687,122
G
Fam217b
family with sequence similarity 217, member B
increases expression
ISO
avobenzone results in increased expression of FAM217B mRNA
CTD
PMID:31016361
NCBI chr 2:178,055,497...178,066,221
Ensembl chr 2:178,056,317...178,066,221
G
Fam241a
family with sequence similarity 241, member A
decreases expression
ISO
avobenzone results in decreased expression of FAM241A mRNA
CTD
PMID:31016361
NCBI chr 3:127,663,337...127,689,972
Ensembl chr 3:127,662,707...127,689,973
G
Fam3c
FAM3 metabolism regulating signaling molecule C
increases expression
ISO
avobenzone results in increased expression of FAM3C mRNA
CTD
PMID:31016361
NCBI chr 6:22,306,519...22,356,080
Ensembl chr 6:22,306,519...22,356,242
G
Fam43a
family with sequence similarity 43, member A
decreases expression
ISO
avobenzone results in decreased expression of FAM43A mRNA
CTD
PMID:31016361
NCBI chr16:30,418,541...30,421,615
Ensembl chr16:30,418,541...30,421,615
G
Fanci
Fanconi anemia, complementation group I
increases expression
ISO
avobenzone results in increased expression of FANCI mRNA
CTD
PMID:31016361
NCBI chr 7:79,042,056...79,100,013
Ensembl chr 7:79,041,677...79,100,012
G
Fasn
fatty acid synthase
increases expression
ISO
avobenzone results in increased expression of FASN mRNA
CTD
PMID:31016361
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
G
Fbn2
fibrillin 2
increases expression
ISO
avobenzone results in increased expression of FBN2 mRNA
CTD
PMID:31016361
NCBI chr18:58,141,689...58,343,200
Ensembl chr18:58,141,695...58,343,559
G
Fbxl20
F-box and leucine-rich repeat protein 20
increases expression
ISO
avobenzone results in increased expression of FBXL20 mRNA
CTD
PMID:31016361
NCBI chr11:97,973,380...98,042,014
Ensembl chr11:97,973,382...98,041,229
G
Fbxo32
F-box protein 32
increases expression
ISO
avobenzone results in increased expression of FBXO32 mRNA
CTD
PMID:31016361
NCBI chr15:58,039,275...58,078,288
Ensembl chr15:58,039,275...58,078,328
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
ISO
avobenzone results in increased expression of FDFT1 mRNA
CTD
PMID:31016361
NCBI chr14:63,382,599...63,419,136
Ensembl chr14:63,382,599...63,417,027
G
Fdps
farnesyl diphosphate synthetase
increases expression
ISO
avobenzone results in increased expression of FDPS mRNA
CTD
PMID:31016361
NCBI chr 3:89,000,895...89,009,274
Ensembl chr 3:89,000,895...89,009,266
G
Fgd6
FYVE, RhoGEF and PH domain containing 6
increases expression
ISO
avobenzone results in increased expression of FGD6 mRNA
CTD
PMID:31016361
NCBI chr10:93,871,862...93,981,201
Ensembl chr10:93,871,863...93,981,201
G
Fibin
fin bud initiation factor homolog (zebrafish)
decreases expression
ISO
avobenzone results in decreased expression of FIBIN mRNA
CTD
PMID:31016361
NCBI chr 2:110,191,270...110,193,338
Ensembl chr 2:110,191,262...110,193,528
G
Filip1l
filamin A interacting protein 1-like
decreases expression
ISO
avobenzone results in decreased expression of FILIP1L mRNA
CTD
PMID:31016361
NCBI chr16:57,173,376...57,393,167
Ensembl chr16:57,173,456...57,393,489
G
Flg
filaggrin
decreases expression
ISO
avobenzone results in decreased expression of FLG mRNA
CTD
PMID:31016361
NCBI chr 3:93,180,853...93,200,996
Ensembl chr 3:93,180,830...93,200,993
G
Flg2
filaggrin family member 2
decreases expression
ISO
avobenzone results in decreased expression of FLG2 mRNA
CTD
PMID:31016361
NCBI chr 3:93,104,585...93,128,701
Ensembl chr 3:93,104,585...93,128,698
G
Fos
FBJ osteosarcoma oncogene
decreases expression
ISO
avobenzone results in decreased expression of FOS mRNA
CTD
PMID:31016361
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Foxk1
forkhead box K1
increases expression
ISO
avobenzone results in increased expression of FOXK1 mRNA
CTD
PMID:31016361
NCBI chr 5:142,387,252...142,447,770
Ensembl chr 5:142,387,252...142,447,766
G
Foxp2
forkhead box P2
decreases expression
ISO
avobenzone results in decreased expression of FOXP2 mRNA
CTD
PMID:31016361
NCBI chr 6:14,901,348...15,441,976
Ensembl chr 6:14,901,348...15,441,976
G
Fry
FRY microtubule binding protein
decreases expression
ISO
avobenzone results in decreased expression of FRY mRNA
CTD
PMID:31016361
NCBI chr 5:150,042,083...150,421,218
Ensembl chr 5:150,042,110...150,421,218
G
Fzd2
frizzled class receptor 2
increases expression
ISO
avobenzone results in increased expression of FZD2 mRNA
CTD
PMID:31016361
NCBI chr11:102,495,257...102,498,884
Ensembl chr11:102,495,222...102,498,884
G
Gabarapl1
GABA type A receptor associated protein like 1
increases expression
ISO
avobenzone results in increased expression of GABARAPL1 mRNA
CTD
PMID:31016361
NCBI chr 6:129,510,155...129,519,294
Ensembl chr 6:129,510,123...129,519,309
G
Gask1b
golgi associated kinase 1B
increases expression
ISO
avobenzone results in increased expression of GASK1B mRNA
CTD
PMID:31016361
NCBI chr 3:79,791,795...79,853,585
Ensembl chr 3:79,791,840...79,853,587
G
Gcat
glycine C-acetyltransferase (2-amino-3-ketobutyrate-coenzyme A ligase)
increases expression
ISO
avobenzone results in increased expression of GCAT mRNA
CTD
PMID:31016361
NCBI chr15:78,915,074...78,926,731
Ensembl chr15:78,915,074...78,922,553 Ensembl chr15:78,915,074...78,922,553
G
Gchfr
GTP cyclohydrolase I feedback regulator
increases expression
ISO
avobenzone results in increased expression of GCHFR mRNA
CTD
PMID:31016361
NCBI chr 2:118,998,269...119,002,870
Ensembl chr 2:118,998,254...119,002,871
G
Gdap1
ganglioside-induced differentiation-associated-protein 1
decreases expression
ISO
avobenzone results in decreased expression of GDAP1 mRNA
CTD
PMID:31016361
NCBI chr 1:17,202,028...17,234,513
Ensembl chr 1:17,215,586...17,234,495
G
Gen1
GEN1, Holliday junction 5' flap endonuclease
decreases expression
ISO
avobenzone results in decreased expression of GEN1 mRNA
CTD
PMID:31016361
NCBI chr12:11,288,929...11,316,030
Ensembl chr12:11,288,921...11,315,802
G
Ggact
gamma-glutamylamine cyclotransferase
decreases expression
ISO
avobenzone results in decreased expression of GGACT mRNA
CTD
PMID:31016361
NCBI chr14:123,128,272...123,151,173
Ensembl chr14:123,053,635...123,151,169
G
Gjb6
gap junction protein, beta 6
decreases expression
ISO
avobenzone results in decreased expression of GJB6 mRNA
CTD
PMID:31016361
NCBI chr14:57,360,760...57,370,764
Ensembl chr14:57,360,760...57,371,068
G
Glul
glutamate-ammonia ligase
increases expression
ISO
avobenzone results in increased expression of GLUL mRNA
CTD
PMID:31016361
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
G
Gm11837
predicted gene 11837
increases expression
ISO
avobenzone results in increased expression of C8ORF88 mRNA
CTD
PMID:31016361
NCBI chr 4:14,929,908...14,953,030
Ensembl chr 4:14,929,851...14,953,031
G
Gm40318
predicted gene, 40318
decreases expression
ISO
avobenzone results in decreased expression of S100P mRNA
CTD
PMID:31016361
NCBI chr 5:36,919,848...36,924,763
Ensembl chr 5:36,919,961...36,924,039
G
Gm5617
predicted gene 5617
decreases expression
ISO
avobenzone results in decreased expression of C11ORF71 mRNA
CTD
PMID:31016361
NCBI chr 9:48,406,643...48,407,275
Ensembl chr 9:48,406,742...48,407,272
G
Gne
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
increases expression
ISO
avobenzone results in increased expression of GNE mRNA
CTD
PMID:31016361
NCBI chr 4:44,034,075...44,084,177
Ensembl chr 4:44,034,075...44,084,177
G
Gpnmb
glycoprotein (transmembrane) nmb
increases expression
ISO
avobenzone results in increased expression of GPNMB mRNA
CTD
PMID:31016361
NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
G
Gsk3b
glycogen synthase kinase 3 beta
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of GSK3B protein
CTD
PMID:29981360
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Gspt2
G1 to S phase transition 2
decreases expression
ISO
avobenzone results in decreased expression of GSPT2 mRNA
CTD
PMID:31016361
NCBI chr X:93,679,675...93,682,168
Ensembl chr X:93,679,675...93,686,850
G
Gstp1
glutathione S-transferase, pi 1
multiple interactions
ISO
avobenzone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Gtf3c2
general transcription factor IIIC, polypeptide 2, beta
increases expression
ISO
avobenzone results in increased expression of GTF3C2 mRNA
CTD
PMID:31016361
NCBI chr 5:31,313,350...31,337,488
Ensembl chr 5:31,313,349...31,337,488
G
Habp4
hyaluronic acid binding protein 4
increases expression
ISO
avobenzone results in increased expression of HABP4 mRNA
CTD
PMID:31016361
NCBI chr13:64,309,680...64,334,351
Ensembl chr13:64,309,638...64,334,351
G
Harbi1
harbinger transposase derived 1
decreases expression
ISO
avobenzone results in decreased expression of HARBI1 mRNA
CTD
PMID:31016361
NCBI chr 2:91,541,197...91,554,016
Ensembl chr 2:91,541,197...91,551,890
G
Hcar2
hydroxycarboxylic acid receptor 2
increases expression
ISO
avobenzone results in increased expression of HCAR3 mRNA
CTD
PMID:31016361
NCBI chr 5:124,001,633...124,003,579
Ensembl chr 5:124,001,633...124,003,562
G
Heg1
heart development protein with EGF-like domains 1
increases expression
ISO
avobenzone results in increased expression of HEG1 mRNA
CTD
PMID:31016361
NCBI chr16:33,504,754...33,591,946
Ensembl chr16:33,504,740...33,591,946
G
Henmt1
HEN1 methyltransferase homolog 1 (Arabidopsis)
decreases expression
ISO
avobenzone results in decreased expression of HENMT1 mRNA
CTD
PMID:31016361
NCBI chr 3:108,846,770...108,887,201
Ensembl chr 3:108,847,375...108,868,090
G
Hes5
hes family bHLH transcription factor 5
decreases expression
ISO
avobenzone results in decreased expression of HES5 mRNA
CTD
PMID:31016361
NCBI chr 4:155,042,358...155,046,829
Ensembl chr 4:155,045,380...155,046,828
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
increases expression
ISO
avobenzone results in increased expression of HMGCR mRNA
CTD
PMID:31016361 PMID:32407875
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmgcs1
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
increases expression
ISO
avobenzone results in increased expression of HMGCS1 mRNA
CTD
PMID:31016361 PMID:32407875
NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796
G
Homez
homeodomain leucine zipper-encoding gene
decreases expression
ISO
avobenzone results in decreased expression of HOMEZ mRNA
CTD
PMID:31016361
NCBI chr14:55,090,193...55,109,285
Ensembl chr14:55,090,193...55,108,418
G
Hp1bp3
heterochromatin protein 1, binding protein 3
increases expression
ISO
avobenzone results in increased expression of HP1BP3 mRNA
CTD
PMID:31016361
NCBI chr 4:137,943,781...137,971,994
Ensembl chr 4:137,943,607...137,971,994
G
Hs3st6
heparan sulfate (glucosamine) 3-O-sulfotransferase 6
decreases expression
ISO
avobenzone results in decreased expression of HS3ST6 mRNA
CTD
PMID:31016361
NCBI chr17:24,971,565...24,977,664
Ensembl chr17:24,971,962...24,977,658
G
Hsd17b14
hydroxysteroid (17-beta) dehydrogenase 14
increases expression
ISO
avobenzone results in increased expression of HSD17B14 mRNA
CTD
PMID:31016361
NCBI chr 7:45,204,345...45,216,745
Ensembl chr 7:45,204,317...45,217,176
G
Id1
inhibitor of DNA binding 1, HLH protein
decreases expression
ISO
avobenzone results in decreased expression of ID1 mRNA
CTD
PMID:31016361
NCBI chr 2:152,578,171...152,579,330
Ensembl chr 2:152,578,171...152,579,330
G
Id4
inhibitor of DNA binding 4
decreases expression
ISO
avobenzone results in decreased expression of ID4 mRNA
CTD
PMID:31016361
NCBI chr13:48,414,592...48,419,504
Ensembl chr13:48,414,704...48,419,502
G
Idi1
isopentenyl-diphosphate delta isomerase
increases expression
ISO
avobenzone results in increased expression of IDI1 mRNA
CTD
PMID:31016361
NCBI chr13:8,935,642...8,942,432
Ensembl chr13:8,935,537...8,942,487
G
Idnk
idnK gluconokinase homolog (E. coli)
decreases expression
ISO
avobenzone results in decreased expression of IDNK mRNA
CTD
PMID:31016361
NCBI chr13:58,305,076...58,315,358
Ensembl chr13:58,305,463...58,312,507
G
Ifi27
interferon, alpha-inducible protein 27
multiple interactions increases expression
ISO
avobenzone inhibits the reaction [IFI27 mRNA results in increased expression of BTBD7 mRNA]; IFI27 mRNA inhibits the reaction [avobenzone results in decreased expression of BTBD7 mRNA] avobenzone results in increased expression of IFI27 mRNA
CTD
PMID:29981360
NCBI chr12:103,400,448...103,406,504
Ensembl chr12:103,400,470...103,406,498
G
Ifi27l2a
interferon, alpha-inducible protein 27 like 2A
increases expression
ISO
avobenzone results in increased expression of IFI27L2 mRNA
CTD
PMID:29981360
NCBI chr12:103,400,132...103,409,939
Ensembl chr12:103,408,426...103,409,939
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
decreases expression
ISO
avobenzone results in decreased expression of IFIT3 mRNA
CTD
PMID:31016361
NCBI chr19:34,560,519...34,566,382
Ensembl chr19:34,560,931...34,566,131
G
Ift70b
intraflagellar transport 70B
decreases expression
ISO
avobenzone results in decreased expression of IFT70B mRNA
CTD
PMID:31016361
NCBI chr 2:75,766,193...75,768,806
Ensembl chr 2:75,766,193...75,768,929
G
Igfbp7
insulin-like growth factor binding protein 7
increases expression
ISO
avobenzone results in increased expression of IGFBP7 mRNA
CTD
PMID:31016361
NCBI chr 5:77,497,092...77,555,892
Ensembl chr 5:77,497,087...77,555,888
G
Ikbip
IKBKB interacting protein
increases expression
ISO
avobenzone results in increased expression of IKBIP mRNA
CTD
PMID:31016361
NCBI chr10:90,918,667...90,938,475
Ensembl chr10:90,918,802...90,938,469
G
Il18r1
interleukin 18 receptor 1
decreases expression
ISO
avobenzone results in decreased expression of IL18R1 mRNA
CTD
PMID:31016361
NCBI chr 1:40,504,712...40,540,014
Ensembl chr 1:40,504,712...40,540,014
G
Il33
interleukin 33
increases expression
ISO
avobenzone results in increased expression of IL33 mRNA
CTD
PMID:31016361
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Impa2
inositol monophosphatase 2
decreases expression
ISO
avobenzone results in decreased expression of IMPA2 mRNA
CTD
PMID:31016361
NCBI chr18:67,422,246...67,454,375
Ensembl chr18:67,422,256...67,455,542
G
Inf2
inverted formin, FH2 and WH2 domain containing
increases expression
ISO
avobenzone results in increased expression of INF2 mRNA
CTD
PMID:31016361
NCBI chr12:112,555,121...112,581,991
Ensembl chr12:112,555,218...112,581,991
G
Ing1
inhibitor of growth family, member 1
increases expression
ISO
avobenzone results in increased expression of ING1 mRNA
CTD
PMID:31016361
NCBI chr 8:11,605,762...11,613,251
Ensembl chr 8:11,605,571...11,613,251
G
Ins1
insulin I
multiple interactions
ISO
avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]
CTD
PMID:32407875
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
G
Ins2
insulin II
multiple interactions
ISO
[avobenzone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARA mRNA; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of TNFRSF11B mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased secretion of TNFRSF11B protein]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; T 0070907 affects the reaction [avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]
CTD
PMID:31016361
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
G
Insig1
insulin induced gene 1
increases expression
ISO
avobenzone results in increased expression of INSIG1 mRNA
CTD
PMID:31016361
NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660
G
Irs2
insulin receptor substrate 2
increases expression
ISO
avobenzone results in increased expression of IRS2 mRNA
CTD
PMID:31016361
NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458
G
Irx3
Iroquois related homeobox 3
decreases expression
ISO
avobenzone results in decreased expression of IRX3 mRNA
CTD
PMID:31016361
NCBI chr 8:92,525,139...92,528,282
Ensembl chr 8:92,525,153...92,528,695
G
Itpkb
inositol 1,4,5-trisphosphate 3-kinase B
increases expression
ISO
avobenzone results in increased expression of ITPKB mRNA
CTD
PMID:31016361
NCBI chr 1:180,156,655...180,252,367
Ensembl chr 1:180,158,050...180,252,367
G
Jmy
junction-mediating and regulatory protein
increases expression
ISO
avobenzone results in increased expression of JMY mRNA
CTD
PMID:31016361
NCBI chr13:93,566,605...93,636,316
Ensembl chr13:93,566,609...93,636,316
G
Jpx
Jpx transcript, Xist activator (non-protein coding)
decreases expression
ISO
avobenzone results in decreased expression of JPX mRNA
CTD
PMID:31016361
NCBI chr X:102,537,164...102,550,031
Ensembl chr X:102,537,158...102,609,302
G
Jrk
jerky
increases expression
ISO
avobenzone results in increased expression of JRK mRNA
CTD
PMID:31016361
NCBI chr15:74,574,261...74,581,171
Ensembl chr15:74,574,150...74,581,384
G
Jrkl
Jrk-like
decreases expression
ISO
avobenzone results in decreased expression of JRKL mRNA
CTD
PMID:31016361
NCBI chr 9:13,242,795...13,245,746
Ensembl chr 9:13,242,612...13,245,834
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
decreases expression
ISO
avobenzone results in decreased expression of KCNJ5 mRNA
CTD
PMID:31016361
NCBI chr 9:32,226,002...32,255,640
Ensembl chr 9:32,226,003...32,255,646
G
Kctd11
potassium channel tetramerisation domain containing 11
decreases expression
ISO
avobenzone results in decreased expression of KCTD11 mRNA
CTD
PMID:31016361
NCBI chr11:69,769,090...69,771,811
Ensembl chr11:69,769,087...69,772,232
G
Kdelr3
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3
increases expression
ISO
avobenzone results in increased expression of KDELR3 mRNA
CTD
PMID:31016361
NCBI chr15:79,400,609...79,411,940
Ensembl chr15:79,400,612...79,411,940
G
Klf10
Kruppel-like transcription factor 10
decreases expression
ISO
avobenzone results in decreased expression of KLF10 mRNA
CTD
PMID:31016361
NCBI chr15:38,291,702...38,300,950
Ensembl chr15:38,291,707...38,300,950
G
Klf16
Kruppel-like transcription factor 16
increases expression
ISO
avobenzone results in increased expression of KLF16 mRNA
CTD
PMID:31016361
NCBI chr10:80,402,955...80,413,130
Ensembl chr10:80,402,958...80,413,155
G
Klhl24
kelch-like 24
increases expression
ISO
avobenzone results in increased expression of KLHL24 mRNA
CTD
PMID:31016361
NCBI chr16:19,916,286...19,947,976
Ensembl chr16:19,916,292...19,947,971
G
Klhl9
kelch-like 9
decreases expression
ISO
avobenzone results in decreased expression of KLHL9 mRNA
CTD
PMID:31016361
NCBI chr 4:88,636,529...88,640,745
Ensembl chr 4:88,636,529...88,640,702
G
Kmt2d
lysine (K)-specific methyltransferase 2D
increases expression
ISO
avobenzone results in increased expression of KMT2D mRNA
CTD
PMID:31016361
NCBI chr15:98,729,550...98,771,958
Ensembl chr15:98,729,550...98,769,085
G
Krcc1
lysine-rich coiled-coil 1
decreases expression
ISO
avobenzone results in decreased expression of KRCC1 mRNA
CTD
PMID:31016361
NCBI chr 6:71,248,661...71,263,809
Ensembl chr 6:71,248,661...71,262,303
G
Krt1
keratin 1
decreases expression
ISO
avobenzone results in decreased expression of KRT1 mRNA
CTD
PMID:31016361
NCBI chr15:101,753,861...101,759,221
Ensembl chr15:101,753,861...101,759,229
G
Krtap19-1
keratin associated protein 19-1
increases expression
ISO
avobenzone results in increased expression of KRTAP19-1 mRNA
CTD
PMID:31016361
NCBI chr16:88,665,806...88,666,298
Ensembl chr16:88,665,805...88,666,299
G
Krtap8-1
keratin associated protein 8-1
decreases expression
ISO
avobenzone results in decreased expression of KRTAP8-1 mRNA
CTD
PMID:31016361
NCBI chr16:89,284,262...89,284,840
Ensembl chr16:89,284,267...89,284,840
G
Kyat1
kynurenine aminotransferase 1
increases expression
ISO
avobenzone results in increased expression of KYAT1 mRNA
CTD
PMID:31016361
NCBI chr 2:30,075,136...30,096,307
Ensembl chr 2:30,075,136...30,095,859
G
L3mbtl1
L3MBTL1 histone methyl-lysine binding protein
increases expression
ISO
avobenzone results in increased expression of L3MBTL1 mRNA
CTD
PMID:31016361
NCBI chr 2:162,784,260...162,819,726
Ensembl chr 2:162,785,392...162,816,442
G
Lactb
lactamase, beta
increases expression
ISO
avobenzone results in increased expression of LACTB mRNA
CTD
PMID:31016361
NCBI chr 9:66,862,668...66,882,706
Ensembl chr 9:66,862,670...66,882,766
G
Lamp3
lysosomal-associated membrane protein 3
decreases expression
ISO
avobenzone results in decreased expression of LAMP3 mRNA
CTD
PMID:31016361
NCBI chr16:19,472,131...19,525,115
Ensembl chr16:19,472,128...19,525,125
G
Lcmt2
leucine carboxyl methyltransferase 2
decreases expression
ISO
avobenzone results in decreased expression of LCMT2 mRNA
CTD
PMID:31016361
NCBI chr 2:120,967,773...120,971,179
Ensembl chr 2:120,958,788...120,971,134
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
avobenzone results in increased expression of LDLR mRNA
CTD
PMID:31016361
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
G
Lima1
LIM domain and actin binding 1
increases expression
ISO
avobenzone results in increased expression of LIMA1 mRNA
CTD
PMID:31016361
NCBI chr15:99,676,351...99,773,292
Ensembl chr15:99,676,351...99,773,337
G
Lix1l
Lix1-like
increases expression
ISO
avobenzone results in increased expression of LIX1L mRNA
CTD
PMID:31016361
NCBI chr 3:96,508,449...96,532,668
Ensembl chr 3:96,508,465...96,533,487
G
Lmln
leishmanolysin-like (metallopeptidase M8 family)
decreases expression
ISO
avobenzone results in decreased expression of LMLN mRNA
CTD
PMID:31016361
NCBI chr16:32,881,974...32,948,065
Ensembl chr16:32,882,891...32,948,065
G
Lnx1
ligand of numb-protein X 1
increases expression
ISO
avobenzone results in increased expression of LNX1 mRNA
CTD
PMID:31016361
NCBI chr 5:74,753,108...74,865,203
Ensembl chr 5:74,753,108...74,863,573
G
Loricrin
loricrin cornified envelope precursor protein
decreases expression
ISO
avobenzone results in decreased expression of LORICRIN mRNA
CTD
PMID:31016361
NCBI chr 3:91,987,578...91,990,447
Ensembl chr 3:91,987,578...91,990,449
G
Lpcat4
lysophosphatidylcholine acyltransferase 4
increases expression
ISO
avobenzone results in increased expression of LPCAT4 mRNA
CTD
PMID:31016361
NCBI chr 2:112,070,186...112,077,456
Ensembl chr 2:112,069,813...112,077,456
G
Lpin1
lipin 1
increases expression
ISO
avobenzone results in increased expression of LPIN1 mRNA
CTD
PMID:31016361
NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967
G
Lrrc8d
leucine rich repeat containing 8D
decreases expression
ISO
avobenzone results in decreased expression of LRRC8D mRNA
CTD
PMID:31016361
NCBI chr 5:105,847,829...105,963,081
Ensembl chr 5:105,847,835...105,980,302
G
Lss
lanosterol synthase
increases expression
ISO
avobenzone results in increased expression of LSS mRNA
CTD
PMID:31016361
NCBI chr10:76,367,303...76,392,973
Ensembl chr10:76,367,422...76,392,972
G
Luc7l
Luc7-like
increases expression
ISO
avobenzone results in increased expression of LUC7L mRNA
CTD
PMID:31016361
NCBI chr17:26,471,874...26,504,484
Ensembl chr17:26,471,870...26,504,478
G
Ly9
lymphocyte antigen 9
increases expression
ISO
avobenzone results in increased expression of LY9 mRNA
CTD
PMID:31016361
NCBI chr 1:171,416,172...171,434,917
Ensembl chr 1:171,416,192...171,434,978
G
Lynx1
Ly6/neurotoxin 1
increases expression
ISO
avobenzone results in increased expression of LYNX1 mRNA
CTD
PMID:31016361
NCBI chr15:74,619,705...74,624,828
Ensembl chr15:74,619,701...74,624,895
G
Lypd6b
LY6/PLAUR domain containing 6B
decreases expression
ISO
avobenzone results in decreased expression of LYPD6B mRNA
CTD
PMID:31016361
NCBI chr 2:49,677,380...49,838,861
Ensembl chr 2:49,677,700...49,838,861
G
Mab21l3
mab-21-like 3
decreases expression
ISO
avobenzone results in decreased expression of MAB21L3 mRNA
CTD
PMID:31016361
NCBI chr 3:101,720,392...101,743,601
Ensembl chr 3:101,720,392...101,756,275
G
Mafb
MAF bZIP transcription factor B
decreases expression
ISO
avobenzone results in decreased expression of MAFB mRNA
CTD
PMID:31016361
NCBI chr 2:160,205,597...160,208,985
Ensembl chr 2:160,205,623...160,208,985
G
Maged2
MAGE family member D2
increases expression
ISO
avobenzone results in increased expression of MAGED2 mRNA
CTD
PMID:31016361
NCBI chr X:149,589,417...149,597,358
Ensembl chr X:149,589,366...149,597,341
G
Magee1
MAGE family member E1
increases expression
ISO
avobenzone results in increased expression of MAGEE1 mRNA
CTD
PMID:31016361
NCBI chr X:104,163,984...104,167,567
Ensembl chr X:104,163,984...104,167,533
G
Maml3
mastermind like transcriptional coactivator 3
decreases expression
ISO
avobenzone results in decreased expression of MAML3 mRNA
CTD
PMID:31016361
NCBI chr 3:51,595,032...52,012,740
Ensembl chr 3:51,593,328...52,012,497
G
Mapk1
mitogen-activated protein kinase 1
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of MAPK1 protein
CTD
PMID:29981360
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of MAPK3 protein
CTD
PMID:29981360
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mblac2
metallo-beta-lactamase domain containing 2
decreases expression
ISO
avobenzone results in decreased expression of MBLAC2 mRNA
CTD
PMID:31016361
NCBI chr13:81,859,536...81,901,394
Ensembl chr13:81,859,460...81,901,394
G
Mcm4
minichromosome maintenance complex component 4
increases expression
ISO
avobenzone results in increased expression of MCM4 mRNA
CTD
PMID:31016361
NCBI chr16:15,441,761...15,455,264
Ensembl chr16:15,441,761...15,455,264
G
Mcm5
minichromosome maintenance complex component 5
increases expression
ISO
avobenzone results in increased expression of MCM5 mRNA
CTD
PMID:31016361
NCBI chr 8:75,836,096...75,855,067
Ensembl chr 8:75,836,197...75,855,067
G
Mdm2
transformed mouse 3T3 cell double minute 2
increases expression
ISO
avobenzone results in increased expression of MDM2 mRNA
CTD
PMID:31016361
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Mettl21a
methyltransferase 21A, HSPA lysine
increases expression
ISO
avobenzone results in increased expression of METTL21A mRNA
CTD
PMID:31016361
NCBI chr 1:64,645,632...64,661,926
Ensembl chr 1:64,645,632...64,656,401
G
Mfap3l
microfibrillar-associated protein 3-like
decreases expression
ISO
avobenzone results in decreased expression of MFAP3L mRNA
CTD
PMID:31016361
NCBI chr 8:61,085,859...61,129,765
Ensembl chr 8:61,085,861...61,129,763
G
Mib1
MIB E3 ubiquitin protein ligase 1
increases expression
ISO
avobenzone results in increased expression of MIB1 mRNA
CTD
PMID:31016361
NCBI chr18:10,725,523...10,822,969
Ensembl chr18:10,725,548...10,818,704
G
Micall2
MICAL-like 2
increases expression
ISO
avobenzone results in increased expression of MICALL2 mRNA
CTD
PMID:31016361
NCBI chr 5:139,692,447...139,722,088
Ensembl chr 5:139,692,451...139,722,091
G
Mill2
MHC I like leukocyte 2
increases expression
ISO
avobenzone results in increased expression of MICB mRNA
CTD
PMID:31016361
NCBI chr 7:18,573,878...18,603,621
Ensembl chr 7:18,573,891...18,599,327
G
Mmp3
matrix metallopeptidase 3
decreases expression
ISO
avobenzone results in decreased expression of MMP3 mRNA
CTD
PMID:31016361
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mnd1
meiotic nuclear divisions 1
increases expression
ISO
avobenzone results in increased expression of MND1 mRNA
CTD
PMID:31016361
NCBI chr 3:83,995,240...84,063,084
Ensembl chr 3:83,995,240...84,063,093
G
Mocs3
molybdenum cofactor synthesis 3
decreases expression
ISO
avobenzone results in decreased expression of MOCS3 mRNA
CTD
PMID:31016361
NCBI chr 2:168,072,542...168,074,223
Ensembl chr 2:168,072,542...168,074,514
G
Morf4l1
mortality factor 4 like 1
increases expression
ISO
avobenzone results in increased expression of MORF4L1 mRNA
CTD
PMID:31016361
NCBI chr 9:89,973,722...89,996,873
Ensembl chr 9:89,973,718...89,996,827
G
Mrpl39
mitochondrial ribosomal protein L39
increases expression
ISO
avobenzone results in increased expression of MRPL39 mRNA
CTD
PMID:31016361
NCBI chr16:84,515,068...84,532,261
Ensembl chr16:84,514,464...84,532,630
G
Msantd3
Myb/SANT-like DNA-binding domain containing 3
increases expression
ISO
avobenzone results in increased expression of MSANTD3 mRNA
CTD
PMID:31016361
NCBI chr 4:48,539,532...48,565,892
Ensembl chr 4:48,539,935...48,561,919
G
Msto1
misato 1, mitochondrial distribution and morphology regulator
decreases expression
ISO
avobenzone results in decreased expression of MSTO1 mRNA
CTD
PMID:31016361
NCBI chr 3:88,816,923...88,821,257
Ensembl chr 3:88,812,414...88,821,306
G
Mt1
metallothionein 1
increases expression
ISO
avobenzone results in increased expression of MT1X mRNA
CTD
PMID:31016361
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
G
Mt2
metallothionein 2
increases expression
ISO
avobenzone results in increased expression of MT2A mRNA
CTD
PMID:31016361
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Muc15
mucin 15
decreases expression
ISO
avobenzone results in decreased expression of MUC15 mRNA
CTD
PMID:31016361
NCBI chr 2:110,551,839...110,569,882
Ensembl chr 2:110,551,685...110,569,872
G
Mvd
mevalonate (diphospho) decarboxylase
increases expression
ISO
avobenzone results in increased expression of MVD mRNA
CTD
PMID:31016361
NCBI chr 8:123,160,335...123,170,161
Ensembl chr 8:123,160,340...123,170,161
G
Myo3b
myosin IIIB
increases expression
ISO
avobenzone results in increased expression of MYO3B mRNA
CTD
PMID:31016361
NCBI chr 2:69,869,464...70,259,542
Ensembl chr 2:69,869,470...70,259,542
G
N4bp2l1
NEDD4 binding protein 2-like 1
increases expression
ISO
avobenzone results in increased expression of N4BP2L1 mRNA
CTD
PMID:31016361
NCBI chr 5:150,495,108...150,518,288
Ensembl chr 5:150,495,109...150,520,653
G
Ncoa5
nuclear receptor coactivator 5
decreases expression
ISO
avobenzone results in decreased expression of NCOA5 mRNA
CTD
PMID:31016361
NCBI chr 2:164,842,273...164,876,794
Ensembl chr 2:164,842,277...164,876,787
G
Ndufa4l2
Ndufa4, mitochondrial complex associated like 2
decreases expression
ISO
avobenzone results in decreased expression of NDUFA4L2 mRNA
CTD
PMID:31016361
NCBI chr10:127,345,143...127,353,023
Ensembl chr10:127,350,836...127,353,023
G
Nedd4
neural precursor cell expressed, developmentally down-regulated 4
decreases expression
ISO
avobenzone results in decreased expression of NEDD4 mRNA
CTD
PMID:31016361
NCBI chr 9:72,569,613...72,657,133
Ensembl chr 9:72,569,628...72,657,134
G
Nhlrc2
NHL repeat containing 2
increases expression
ISO
avobenzone results in increased expression of NHLRC2 mRNA
CTD
PMID:31016361
NCBI chr19:56,536,682...56,591,935
Ensembl chr19:56,536,693...56,591,935
G
Nipal3
NIPA-like domain containing 3
increases expression
ISO
avobenzone results in increased expression of NIPAL3 mRNA
CTD
PMID:31016361
NCBI chr 4:135,173,454...135,222,283
Ensembl chr 4:135,172,731...135,222,349
G
Nkpd1
NTPase, KAP family P-loop domain containing 1
decreases expression
ISO
avobenzone results in decreased expression of NKPD1 mRNA
CTD
PMID:31016361
NCBI chr 7:19,251,404...19,258,982
Ensembl chr 7:19,251,763...19,258,981
G
Noct
nocturnin
increases expression
ISO
avobenzone results in increased expression of NOCT mRNA
CTD
PMID:31016361
NCBI chr 3:51,131,868...51,159,075
Ensembl chr 3:51,131,868...51,159,065
G
Nomo1
nodal modulator 1
increases expression
ISO
avobenzone results in increased expression of NOMO3 mRNA
CTD
PMID:31016361
NCBI chr 7:45,683,120...45,733,636
Ensembl chr 7:45,683,122...45,733,636
G
Npas2
neuronal PAS domain protein 2
increases expression
ISO
avobenzone results in increased expression of NPAS2 mRNA
CTD
PMID:31016361
NCBI chr 1:39,233,013...39,402,321
Ensembl chr 1:39,232,812...39,402,317
G
Npepl1
aminopeptidase-like 1
decreases expression
ISO
avobenzone results in decreased expression of NPEPL1 mRNA
CTD
PMID:31016361
NCBI chr 2:173,951,904...173,964,495
Ensembl chr 2:173,952,142...173,964,863
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
increases expression
ISO
avobenzone results in increased expression of NQO1 mRNA
CTD
PMID:31016361
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
increases expression
ISO
avobenzone results in increased expression of NR1D2 mRNA
CTD
PMID:31016361
NCBI chr14:4,230,549...4,265,639
Ensembl chr14:4,230,569...4,265,642
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
affects binding
ISO
avobenzone binds to NR3C1 protein
CTD
PMID:28115641
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Nub1
negative regulator of ubiquitin-like proteins 1
increases expression
ISO
avobenzone results in increased expression of NUB1 mRNA
CTD
PMID:31016361
NCBI chr 5:24,890,813...24,915,376
Ensembl chr 5:24,890,530...24,915,376
G
Nwd2
NACHT and WD repeat domain containing 2
decreases expression
ISO
avobenzone results in decreased expression of NWD2 mRNA
CTD
PMID:31016361
NCBI chr 5:63,806,446...63,967,889
Ensembl chr 5:63,806,445...63,967,889
G
Obsl1
obscurin-like 1
increases expression
ISO
avobenzone results in increased expression of OBSL1 mRNA
CTD
PMID:31016361
NCBI chr 1:75,462,469...75,483,134
Ensembl chr 1:75,455,954...75,483,096
G
Ostm1
osteopetrosis associated transmembrane protein 1
increases expression
ISO
avobenzone results in increased expression of OSTM1 mRNA
CTD
PMID:31016361
NCBI chr10:42,554,912...42,578,458
Ensembl chr10:42,459,818...42,578,455
G
Otud1
OTU domain containing 1
increases expression
ISO
avobenzone results in increased expression of OTUD1 mRNA
CTD
PMID:31016361
NCBI chr 2:19,662,542...19,666,090
Ensembl chr 2:19,662,563...19,665,394
G
P2rx7
purinergic receptor P2X, ligand-gated ion channel, 7
decreases expression
ISO
avobenzone results in decreased expression of P2RX7 mRNA
CTD
PMID:31016361
NCBI chr 5:122,781,990...122,830,399
Ensembl chr 5:122,781,974...122,829,495
G
P2ry1
purinergic receptor P2Y, G-protein coupled 1
decreases expression
ISO
avobenzone results in decreased expression of P2RY1 mRNA
CTD
PMID:31016361
NCBI chr 3:60,910,206...60,916,403
Ensembl chr 3:60,910,216...60,916,403
G
Pappa2
pappalysin 2
decreases expression
ISO
avobenzone results in decreased expression of PAPPA2 mRNA
CTD
PMID:31016361
NCBI chr 1:158,539,297...158,788,019
Ensembl chr 1:158,539,297...158,808,060
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
ISO
avobenzone results in increased expression of PAPSS2 mRNA
CTD
PMID:31016361
NCBI chr19:32,573,072...32,644,587
Ensembl chr19:32,573,190...32,644,587
G
Pard3
par-3 family cell polarity regulator
increases expression
ISO
avobenzone results in increased expression of PARD3 mRNA
CTD
PMID:31016361
NCBI chr 8:127,790,131...128,338,767
Ensembl chr 8:127,790,643...128,338,767
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
decreases expression
ISO
avobenzone results in decreased expression of PCK2 mRNA
CTD
PMID:31016361
NCBI chr14:55,777,721...55,787,477
Ensembl chr14:55,777,723...55,788,699
G
Pclo
piccolo (presynaptic cytomatrix protein)
decreases expression
ISO
avobenzone results in decreased expression of PCLO mRNA
CTD
PMID:31016361
NCBI chr 5:14,564,924...14,913,479
Ensembl chr 5:14,564,932...14,913,473
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
avobenzone results in decreased expression of PCNA protein
CTD
PMID:29981360
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pcolce2
procollagen C-endopeptidase enhancer 2
increases expression
ISO
avobenzone results in increased expression of PCOLCE2 mRNA
CTD
PMID:31016361
NCBI chr 9:95,519,681...95,577,604
Ensembl chr 9:95,519,654...95,580,149
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
increases expression
ISO
avobenzone results in increased expression of PCSK9 mRNA
CTD
PMID:31016361
NCBI chr 4:106,299,531...106,321,522
Ensembl chr 4:106,299,526...106,321,526
G
Pdcd5
programmed cell death 5
increases expression
ISO
avobenzone results in increased expression of PDCD5 mRNA
CTD
PMID:31016361
NCBI chr 7:35,341,410...35,346,907
Ensembl chr 7:35,341,407...35,346,946
G
Pde5a
phosphodiesterase 5A, cGMP-specific
increases expression
ISO
avobenzone results in increased expression of PDE5A mRNA
CTD
PMID:31016361
NCBI chr 3:122,522,822...122,653,023
Ensembl chr 3:122,522,596...122,653,023
G
Pdia4
protein disulfide isomerase associated 4
increases expression
ISO
avobenzone results in increased expression of PDIA4 mRNA
CTD
PMID:31016361
NCBI chr 6:47,773,075...47,790,446
Ensembl chr 6:47,773,075...47,790,364
G
Pdk1
pyruvate dehydrogenase kinase, isoenzyme 1
increases expression
ISO
avobenzone results in increased expression of PDK1 mRNA
CTD
PMID:31016361
NCBI chr 2:71,703,398...71,734,202
Ensembl chr 2:71,703,568...71,734,202
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
increases expression
ISO
avobenzone results in increased expression of PDP2 mRNA
CTD
PMID:31016361
NCBI chr 8:105,318,104...105,325,658
Ensembl chr 8:105,318,083...105,325,658
G
Pdxdc1
pyridoxal-dependent decarboxylase domain containing 1
increases expression
ISO
avobenzone results in increased expression of PDXDC1 mRNA
CTD
PMID:31016361
NCBI chr16:13,651,025...13,721,018
Ensembl chr16:13,651,012...13,720,995
G
Pet100
PET100 homolog
increases expression
ISO
avobenzone results in increased expression of PET100 mRNA
CTD
PMID:31016361
NCBI chr 8:3,671,551...3,674,235
Ensembl chr 8:3,671,548...3,675,848
G
Pex13
peroxisomal biogenesis factor 13
increases expression
ISO
avobenzone results in increased expression of PEX13 mRNA
CTD
PMID:31016361
NCBI chr11:23,597,283...23,615,883
Ensembl chr11:23,596,479...23,615,959
G
Pfdn4
prefoldin 4
increases expression
ISO
avobenzone results in increased expression of PFDN4 mRNA
CTD
PMID:31016361
NCBI chr 2:170,338,348...170,360,987
Ensembl chr 2:170,338,348...170,361,043
G
Phactr3
phosphatase and actin regulator 3
decreases expression
ISO
avobenzone results in decreased expression of PHACTR3 mRNA
CTD
PMID:31016361
NCBI chr 2:177,760,768...177,980,285
Ensembl chr 2:177,760,768...177,980,285
G
Phex
phosphate regulating endopeptidase homolog, X-linked
decreases expression
ISO
avobenzone results in decreased expression of PHEX mRNA
CTD
PMID:31016361
NCBI chr X:155,945,071...156,198,282
Ensembl chr X:155,945,071...156,198,308
G
Phtf2
putative homeodomain transcription factor 2
increases expression
ISO
avobenzone results in increased expression of PHTF2 mRNA
CTD
PMID:31016361
NCBI chr 5:20,963,662...21,087,122
Ensembl chr 5:20,963,661...21,087,122
G
Pi4k2a
phosphatidylinositol 4-kinase type 2 alpha
increases expression
ISO
avobenzone results in increased expression of PI4K2A mRNA
CTD
PMID:31016361
NCBI chr19:42,078,590...42,110,657
Ensembl chr19:42,078,909...42,110,526
G
Pidd1
p53 induced death domain protein 1
increases expression
ISO
avobenzone results in increased expression of PIDD1 mRNA
CTD
PMID:31016361
NCBI chr 7:141,018,026...141,027,477
Ensembl chr 7:141,018,026...141,023,938
G
Pigm
phosphatidylinositol glycan anchor biosynthesis, class M
decreases expression
ISO
avobenzone results in decreased expression of PIGM mRNA
CTD
PMID:31016361
NCBI chr 1:172,204,098...172,211,666
Ensembl chr 1:172,204,113...172,211,666
G
Pik3c2a
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha
increases expression
ISO
avobenzone results in increased expression of PIK3C2A mRNA
CTD
PMID:31016361
NCBI chr 7:115,936,500...116,042,693
Ensembl chr 7:115,936,500...116,042,684
G
Pik3ip1
phosphoinositide-3-kinase interacting protein 1
increases expression
ISO
avobenzone results in increased expression of PIK3IP1 mRNA
CTD
PMID:31016361
NCBI chr11:3,280,731...3,292,971
Ensembl chr11:3,280,401...3,292,971
G
Plau
plasminogen activator, urokinase
increases expression
ISO
avobenzone results in increased expression of PLAU mRNA
CTD
PMID:31016361
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Plekhg3
pleckstrin homology domain containing, family G (with RhoGef domain) member 3
increases expression
ISO
avobenzone results in increased expression of PLEKHG3 mRNA
CTD
PMID:31016361
NCBI chr12:76,580,330...76,627,265
Ensembl chr12:76,577,665...76,627,262
G
Plin2
perilipin 2
decreases expression
ISO
avobenzone results in decreased expression of PLIN2 mRNA
CTD
PMID:31016361
NCBI chr 4:86,545,147...86,588,518
Ensembl chr 4:86,566,623...86,588,297
G
Plpp6
phospholipid phosphatase 6
decreases expression
ISO
avobenzone results in decreased expression of PLPP6 mRNA
CTD
PMID:31016361
NCBI chr19:28,941,320...28,944,201
Ensembl chr19:28,941,353...28,944,211
G
Pnisr
PNN interacting serine/arginine-rich
increases expression
ISO
avobenzone results in increased expression of PNISR mRNA
CTD
PMID:31016361
NCBI chr 4:21,846,621...21,876,475
Ensembl chr 4:21,847,583...21,876,475
G
Polr1has
RNA polymerase I subunit H, antisense
decreases expression
ISO
avobenzone results in decreased expression of POLR1HASP mRNA
CTD
PMID:31016361
NCBI chr17:37,269,483...37,276,722
Ensembl chr17:37,269,484...37,276,517
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions increases expression
ISO
[avobenzone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARA mRNA avobenzone results in increased expression of PPARA mRNA
CTD
PMID:31016361 PMID:32407875
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions increases expression
ISO
avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] avobenzone results in increased expression of PPARG mRNA
CTD
PMID:31016361 PMID:32407875
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppfibp1
PTPRF interacting protein, binding protein 1 (liprin beta 1)
increases expression
ISO
avobenzone results in increased expression of PPFIBP1 mRNA
CTD
PMID:31016361
NCBI chr 6:146,788,107...146,933,523
Ensembl chr 6:146,789,985...146,933,523
G
Ppm1k
protein phosphatase 1K (PP2C domain containing)
increases expression
ISO
avobenzone results in increased expression of PPM1K mRNA
CTD
PMID:31016361
NCBI chr 6:57,483,487...57,512,537
Ensembl chr 6:57,483,487...57,512,453
G
Ppp1r18
protein phosphatase 1, regulatory subunit 18
increases expression
ISO
avobenzone results in increased expression of PPP1R18 mRNA
CTD
PMID:31016361
NCBI chr17:36,176,483...36,186,488
Ensembl chr17:36,176,485...36,186,488
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression
ISO
avobenzone results in decreased expression of PPP1R3C mRNA
CTD
PMID:31016361
NCBI chr19:36,709,131...36,714,004
Ensembl chr19:36,709,131...36,714,053
G
Prkg1
protein kinase, cGMP-dependent, type I
decreases expression
ISO
avobenzone results in decreased expression of PRKG1 mRNA
CTD
PMID:31016361
NCBI chr19:30,541,887...31,742,675
Ensembl chr19:30,541,889...31,742,433
G
Prmt2
protein arginine N-methyltransferase 2
increases expression
ISO
avobenzone results in increased expression of PRMT2 mRNA
CTD
PMID:31016361
NCBI chr10:76,043,060...76,073,699
Ensembl chr10:76,043,056...76,073,699
G
Prmt6
protein arginine N-methyltransferase 6
decreases expression
ISO
avobenzone results in decreased expression of PRMT6 mRNA
CTD
PMID:31016361
NCBI chr 3:110,153,420...110,158,315
Ensembl chr 3:110,153,425...110,158,314
G
Prmt8
protein arginine N-methyltransferase 8
decreases expression
ISO
avobenzone results in decreased expression of PRMT8 mRNA
CTD
PMID:31016361
NCBI chr 6:127,665,972...127,746,430
Ensembl chr 6:127,665,974...127,746,435
G
Prss23
serine protease 23
decreases expression
ISO
avobenzone results in decreased expression of PRSS23 mRNA
CTD
PMID:31016361
NCBI chr 7:89,156,988...89,176,399
Ensembl chr 7:89,156,991...89,176,395
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
avobenzone results in decreased expression of PSAT1 mRNA
CTD
PMID:31016361
NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
G
Pskh1
protein serine kinase H1
decreases expression
ISO
avobenzone results in decreased expression of PSKH1 mRNA
CTD
PMID:31016361
NCBI chr 8:106,627,106...106,658,434
Ensembl chr 8:106,627,073...106,658,410
G
Ptafr
platelet-activating factor receptor
increases expression
ISO
avobenzone results in increased expression of PTAFR mRNA
CTD
PMID:31016361
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
G
Ptpdc1
protein tyrosine phosphatase domain containing 1
increases expression
ISO
avobenzone results in increased expression of PTPDC1 mRNA
CTD
PMID:31016361
NCBI chr13:48,731,345...48,779,148
Ensembl chr13:48,731,348...48,779,140
G
Qprt
quinolinate phosphoribosyltransferase
increases expression
ISO
avobenzone results in increased expression of QPRT mRNA
CTD
PMID:31016361
NCBI chr 7:126,706,942...126,721,201
Ensembl chr 7:126,706,286...126,721,398
G
Rab11fip4
RAB11 family interacting protein 4 (class II)
increases expression
ISO
avobenzone results in increased expression of RAB11FIP4 mRNA
CTD
PMID:31016361
NCBI chr11:79,481,847...79,588,842
Ensembl chr11:79,482,038...79,588,849
G
Rac2
Rac family small GTPase 2
increases expression
ISO
avobenzone results in increased expression of RAC2 mRNA
CTD
PMID:31016361
NCBI chr15:78,443,369...78,456,983
Ensembl chr15:78,443,367...78,456,983
G
Rad18
RAD18 E3 ubiquitin protein ligase
increases expression
ISO
avobenzone results in increased expression of RAD18 mRNA
CTD
PMID:31016361
NCBI chr 6:112,596,812...112,673,650
Ensembl chr 6:112,596,811...112,673,647
G
Raet1e
retinoic acid early transcript 1E
decreases expression
ISO
avobenzone results in decreased expression of RAET1E mRNA
CTD
PMID:31016361
NCBI chr10:22,034,441...22,059,820
Ensembl chr10:22,034,468...22,250,038
G
Ranbp1
RAN binding protein 1
increases expression
ISO
avobenzone results in increased expression of RANBP1 mRNA
CTD
PMID:31016361
NCBI chr16:18,057,843...18,066,558
Ensembl chr16:18,057,648...18,066,596
G
Ranbp6
RAN binding protein 6
decreases expression
ISO
avobenzone results in decreased expression of RANBP6 mRNA
CTD
PMID:31016361
NCBI chr19:29,785,508...29,790,374
Ensembl chr19:29,785,800...29,790,374
G
Rasgrp1
RAS guanyl releasing protein 1
decreases expression
ISO
avobenzone results in decreased expression of RASGRP1 mRNA
CTD
PMID:31016361
NCBI chr 2:117,110,464...117,173,358
Ensembl chr 2:117,110,474...117,173,482
G
Rassf10
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10
decreases expression
ISO
avobenzone results in decreased expression of RASSF10 mRNA
CTD
PMID:31016361
NCBI chr 7:112,553,169...112,556,665
Ensembl chr 7:112,553,169...112,556,664
G
Rbl2
RB transcriptional corepressor like 2
increases expression
ISO
avobenzone results in increased expression of RBL2 mRNA
CTD
PMID:31016361
NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
G
Rbm45
RNA binding motif protein 45
decreases expression
ISO
avobenzone results in decreased expression of RBM45 mRNA
CTD
PMID:31016361
NCBI chr 2:76,200,304...76,214,112
Ensembl chr 2:76,200,328...76,214,112
G
Rbm5
RNA binding motif protein 5
increases expression
ISO
avobenzone results in increased expression of RBM5 mRNA
CTD
PMID:31016361
NCBI chr 9:107,617,694...107,648,228
Ensembl chr 9:107,617,570...107,648,195
G
Rgs5
regulator of G-protein signaling 5
decreases expression
ISO
avobenzone results in decreased expression of RGS5 mRNA
CTD
PMID:31016361
NCBI chr 1:169,483,070...169,523,367
Ensembl chr 1:169,483,070...169,523,382
G
Rnase4
ribonuclease, RNase A family 4
increases expression
ISO
avobenzone results in increased expression of RNASE4 mRNA
CTD
PMID:31016361
NCBI chr14:51,328,534...51,343,608
Ensembl chr14:51,328,534...51,343,608
G
Rnf6
ring finger protein (C3H2C3 type) 6
increases expression
ISO
avobenzone results in increased expression of RNF6 mRNA
CTD
PMID:31016361
NCBI chr 5:146,146,003...146,158,267
Ensembl chr 5:146,146,002...146,158,365
G
Rps6
ribosomal protein S6
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of RPS6 protein
CTD
PMID:29981360
NCBI chr 4:86,772,336...86,775,604
Ensembl chr 4:86,772,897...86,775,649
G
Rps6ka6
ribosomal protein S6 kinase polypeptide 6
decreases expression
ISO
avobenzone results in decreased expression of RPS6KA6 mRNA
CTD
PMID:31016361
NCBI chr X:110,297,534...110,447,794
Ensembl chr X:110,297,889...110,447,656
G
Rps6kb1
ribosomal protein S6 kinase, polypeptide 1
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of RPS6KB1 protein
CTD
PMID:29981360
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
G
Rptn
repetin
decreases expression
ISO
avobenzone results in decreased expression of RPTN mRNA
CTD
PMID:31016361
NCBI chr 3:93,301,006...93,306,749
Ensembl chr 3:93,301,006...93,306,749
G
Rragd
Ras-related GTP binding D
increases expression
ISO
avobenzone results in increased expression of RRAGD mRNA
CTD
PMID:31016361
NCBI chr 4:32,982,998...33,022,180
Ensembl chr 4:32,983,037...33,022,180
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression
ISO
avobenzone results in increased expression of RSAD2 mRNA
CTD
PMID:31016361
NCBI chr12:26,492,742...26,506,451
Ensembl chr12:26,492,745...26,506,451
G
Rsbn1l
round spermatid basic protein 1-like
increases expression
ISO
avobenzone results in increased expression of RSBN1L mRNA
CTD
PMID:31016361
NCBI chr 5:21,097,284...21,163,019
Ensembl chr 5:21,098,026...21,161,396
G
Rundc1
RUN domain containing 1
decreases expression
ISO
avobenzone results in decreased expression of RUNDC1 mRNA
CTD
PMID:31016361
NCBI chr11:101,315,910...101,326,492
Ensembl chr11:101,315,911...101,326,499
G
Samd13
sterile alpha motif domain containing 13
decreases expression
ISO
avobenzone results in decreased expression of SAMD13 mRNA
CTD
PMID:31016361
NCBI chr 3:146,350,944...146,391,555
Ensembl chr 3:146,350,950...146,391,347 Ensembl chr 3:146,350,950...146,391,347
G
Samd4
sterile alpha motif domain containing 4
increases expression
ISO
avobenzone results in increased expression of SAMD4A mRNA
CTD
PMID:31016361
NCBI chr14:47,120,414...47,343,274
Ensembl chr14:47,120,311...47,343,272
G
Samd9l
sterile alpha motif domain containing 9-like
decreases expression
ISO
avobenzone results in decreased expression of SAMD9L mRNA
CTD
PMID:31016361
NCBI chr 6:3,372,257...3,399,458
Ensembl chr 6:3,372,257...3,399,572
G
Scara3
scavenger receptor class A, member 3
increases expression
ISO
avobenzone results in increased expression of SCARA3 mRNA
CTD
PMID:31016361
NCBI chr14:66,156,844...66,191,427
Ensembl chr14:66,156,843...66,191,384
G
Scd2
stearoyl-Coenzyme A desaturase 2
increases expression
ISO
avobenzone results in increased expression of SCD mRNA
CTD
PMID:31016361
NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
G
Scml1
Scm polycomb group protein like 1
increases expression
ISO
avobenzone results in increased expression of SCML1 mRNA
CTD
PMID:31016361
NCBI chr X:160,597,689...160,615,118
Ensembl chr X:160,598,170...160,608,319
G
Sdf2l1
stromal cell-derived factor 2-like 1
increases expression
ISO
avobenzone results in increased expression of SDF2L1 mRNA
CTD
PMID:31016361
NCBI chr16:16,948,002...16,950,247
Ensembl chr16:16,948,002...16,950,247
G
Sec24d
SEC24 homolog D, COPII coat complex component
increases expression
ISO
avobenzone results in increased expression of SEC24D mRNA
CTD
PMID:31016361
NCBI chr 3:123,058,451...123,159,290
Ensembl chr 3:123,061,104...123,159,290
G
Sema6d
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D
decreases expression
ISO
avobenzone results in decreased expression of SEMA6D mRNA
CTD
PMID:31016361
NCBI chr 2:123,931,089...124,509,711
Ensembl chr 2:123,931,889...124,509,690
G
Sephs2
selenophosphate synthetase 2
decreases expression
ISO
avobenzone results in decreased expression of SEPHS2 mRNA
CTD
PMID:31016361
NCBI chr 7:126,871,051...126,873,231
Ensembl chr 7:126,871,051...126,873,227
G
Sft2d3
SFT2 domain containing 3
decreases expression
ISO
avobenzone results in decreased expression of SFT2D3 mRNA
CTD
PMID:31016361
NCBI chr18:32,042,147...32,044,956
Ensembl chr18:32,042,151...32,044,877
G
Sh3bgr
SH3-binding domain glutamic acid-rich protein
decreases expression
ISO
avobenzone results in decreased expression of SH3BGR mRNA
CTD
PMID:31016361
NCBI chr16:96,001,670...96,030,133
Ensembl chr16:96,001,650...96,030,135
G
Slc12a6
solute carrier family 12, member 6
increases expression
ISO
avobenzone results in increased expression of SLC12A6 mRNA
CTD
PMID:31016361
NCBI chr 2:112,096,659...112,193,508
Ensembl chr 2:112,096,170...112,193,508
G
Slc16a9
solute carrier family 16 (monocarboxylic acid transporters), member 9
decreases expression
ISO
avobenzone results in decreased expression of SLC16A9 mRNA
CTD
PMID:31016361
NCBI chr10:70,081,106...70,121,781
Ensembl chr10:70,080,930...70,121,798
G
Slc17a5
solute carrier family 17 (anion/sugar transporter), member 5
increases expression
ISO
avobenzone results in increased expression of SLC17A5 mRNA
CTD
PMID:31016361
NCBI chr 9:78,443,769...78,495,346
Ensembl chr 9:78,443,770...78,495,323
G
Slc25a37
solute carrier family 25, member 37
increases expression
ISO
avobenzone results in increased expression of SLC25A37 mRNA
CTD
PMID:31016361
NCBI chr14:69,479,297...69,522,993
Ensembl chr14:69,479,297...69,522,561
G
Slc2a12
solute carrier family 2 (facilitated glucose transporter), member 12
increases expression
ISO
avobenzone results in increased expression of SLC2A12 mRNA
CTD
PMID:31016361
NCBI chr10:22,488,821...22,579,779
Ensembl chr10:22,520,910...22,580,184
G
Slc2a3
solute carrier family 2 (facilitated glucose transporter), member 3
increases expression
ISO
avobenzone results in increased expression of SLC2A3 mRNA
CTD
PMID:31016361
NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
G
Slc2a8
solute carrier family 2, (facilitated glucose transporter), member 8
increases expression
ISO
avobenzone results in increased expression of SLC2A8 mRNA
CTD
PMID:31016361
NCBI chr 2:32,862,993...32,872,088
Ensembl chr 2:32,863,002...32,872,095
G
Slc33a1
solute carrier family 33 (acetyl-CoA transporter), member 1
increases expression
ISO
avobenzone results in increased expression of SLC33A1 mRNA
CTD
PMID:31016361
NCBI chr 3:63,849,744...63,872,154
Ensembl chr 3:63,840,928...63,872,189
G
Slc5a3
solute carrier family 5 (inositol transporters), member 3
increases expression
ISO
avobenzone results in increased expression of SLC5A3 mRNA
CTD
PMID:31016361
NCBI chr16:91,855,210...91,884,361
Ensembl chr16:91,855,210...91,884,361
G
Slc6a6
solute carrier family 6 (neurotransmitter transporter, taurine), member 6
increases expression
ISO
avobenzone results in increased expression of SLC6A6 mRNA
CTD
PMID:31016361
NCBI chr 6:91,661,031...91,736,044
Ensembl chr 6:91,661,034...91,736,047
G
Smim5
small integral membrane protein 5
decreases expression
ISO
avobenzone results in decreased expression of SMIM5 mRNA
CTD
PMID:31016361
NCBI chr11:115,789,575...115,797,095
Ensembl chr11:115,790,792...115,797,095
G
Smtn
smoothelin
increases expression
ISO
avobenzone results in increased expression of SMTN mRNA
CTD
PMID:31016361
NCBI chr11:3,467,522...3,489,337
Ensembl chr11:3,467,523...3,490,612
G
Snrnp27
small nuclear ribonucleoprotein 27 (U4/U6.U5)
increases expression
ISO
avobenzone results in increased expression of SNRNP27 mRNA
CTD
PMID:31016361
NCBI chr 6:86,652,151...86,661,473
Ensembl chr 6:86,652,133...86,661,504
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
avobenzone results in increased expression of SOCS3 mRNA
CTD
PMID:31016361
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
G
Socs4
suppressor of cytokine signaling 4
decreases expression
ISO
avobenzone results in decreased expression of SOCS4 mRNA
CTD
PMID:31016361
NCBI chr14:47,514,377...47,533,559
Ensembl chr14:47,514,388...47,533,559
G
Sox9
SRY (sex determining region Y)-box 9
increases expression
ISO
avobenzone results in increased expression of SOX9 mRNA
CTD
PMID:31016361
NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586
G
Sparc
secreted acidic cysteine rich glycoprotein
increases expression
ISO
avobenzone results in increased expression of SPARC mRNA
CTD
PMID:31016361
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Spink6
serine peptidase inhibitor, Kazal type 6
increases expression
ISO
avobenzone results in increased expression of SPINK6 mRNA
CTD
PMID:31016361
NCBI chr18:44,204,460...44,216,678
Ensembl chr18:44,204,460...44,216,678
G
Sqle
squalene epoxidase
increases expression
ISO
avobenzone results in increased expression of SQLE mRNA
CTD
PMID:31016361
NCBI chr15:59,186,941...59,203,042
Ensembl chr15:59,186,926...59,203,041
G
Sqstm1
sequestosome 1
increases expression
ISO
avobenzone results in increased expression of SQSTM1 mRNA
CTD
PMID:31016361
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
G
Stc2
stanniocalcin 2
decreases expression
ISO
avobenzone results in decreased expression of STC2 mRNA
CTD
PMID:31016361
NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
G
Stk32c
serine/threonine kinase 32C
increases expression
ISO
avobenzone results in increased expression of STK32C mRNA
CTD
PMID:31016361
NCBI chr 7:138,683,554...138,793,223
Ensembl chr 7:138,683,554...138,793,223
G
Stx19
syntaxin 19
decreases expression
ISO
avobenzone results in decreased expression of STX19 mRNA
CTD
PMID:31016361
NCBI chr16:62,635,039...62,643,085
Ensembl chr16:62,635,039...62,644,709
G
Sugct
succinyl-CoA glutarate-CoA transferase
increases expression
ISO
avobenzone results in increased expression of SUGCT mRNA
CTD
PMID:31016361
NCBI chr13:17,032,057...17,869,380
Ensembl chr13:17,032,057...17,870,138
G
Sult1e1
sulfotransferase family 1E, member 1
decreases expression
ISO
avobenzone results in decreased expression of SULT1E1 mRNA
CTD
PMID:31016361
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
G
Suox
sulfite oxidase
decreases expression
ISO
avobenzone results in decreased expression of SUOX mRNA
CTD
PMID:31016361
NCBI chr10:128,505,756...128,509,787
Ensembl chr10:128,505,763...128,509,942
G
Sybu
syntabulin (syntaxin-interacting)
decreases expression
ISO
avobenzone results in decreased expression of SYBU mRNA
CTD
PMID:31016361
NCBI chr15:44,535,252...44,651,466
Ensembl chr15:44,535,252...44,651,459
G
Sync
syncoilin
decreases expression
ISO
avobenzone results in decreased expression of SYNC mRNA
CTD
PMID:31016361
NCBI chr 4:129,181,066...129,203,175
Ensembl chr 4:129,181,410...129,202,352
G
Taf13
TATA-box binding protein associated factor 13
increases expression
ISO
avobenzone results in increased expression of TAF13 mRNA
CTD
PMID:31016361
NCBI chr 3:108,479,015...108,489,384
Ensembl chr 3:108,479,014...108,490,538
G
Tbc1d2
TBC1 domain family, member 2
increases expression
ISO
avobenzone results in increased expression of TBC1D2 mRNA
CTD
PMID:31016361
NCBI chr 4:46,604,390...46,650,396
Ensembl chr 4:46,604,390...46,650,209
G
Tent5c
terminal nucleotidyltransferase 5C
increases expression
ISO
avobenzone results in increased expression of TENT5C mRNA
CTD
PMID:31016361
NCBI chr 3:100,375,373...100,396,508
Ensembl chr 3:100,358,944...100,396,640
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
ISO
avobenzone results in increased expression of TFPI2 mRNA
CTD
PMID:31016361
NCBI chr 6:3,962,589...3,988,977
Ensembl chr 6:3,962,595...3,988,919
G
Tgfbr2
transforming growth factor, beta receptor II
increases expression
ISO
avobenzone results in increased expression of TGFBR2 mRNA
CTD
PMID:31016361
NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
G
Tgm1
transglutaminase 1, K polypeptide
decreases expression
ISO
avobenzone results in decreased expression of TGM1 mRNA
CTD
PMID:31016361
NCBI chr14:55,937,466...55,951,378
Ensembl chr14:55,937,466...55,951,383
G
Themis2
thymocyte selection associated family member 2
increases expression
ISO
avobenzone results in increased expression of THEMIS2 mRNA
CTD
PMID:31016361
NCBI chr 4:132,509,148...132,523,675
Ensembl chr 4:132,509,154...132,523,698
G
Tm9sf1
transmembrane 9 superfamily member 1
increases expression
ISO
avobenzone results in increased expression of TM9SF1 mRNA
CTD
PMID:31016361
NCBI chr14:55,873,422...55,881,263
Ensembl chr14:55,873,422...55,881,263
G
Tmem139
transmembrane protein 139
decreases expression
ISO
avobenzone results in decreased expression of TMEM139 mRNA
CTD
PMID:31016361
NCBI chr 6:42,238,866...42,241,489
Ensembl chr 6:42,238,893...42,241,489
G
Tmem185b
transmembrane protein 185B
decreases expression
ISO
avobenzone results in decreased expression of TMEM185B mRNA
CTD
PMID:31016361
NCBI chr 1:119,453,884...119,456,713
Ensembl chr 1:119,453,890...119,456,713
G
Tmem250
transmembrane protein 250
decreases expression
ISO
avobenzone results in decreased expression of TMEM250 mRNA
CTD
PMID:31016361
NCBI chr 2:26,026,819...26,030,518
Ensembl chr 2:26,026,826...26,030,533
G
Tmem67
transmembrane protein 67
decreases expression
ISO
avobenzone results in decreased expression of TMEM67 mRNA
CTD
PMID:31016361
NCBI chr 4:12,039,355...12,090,020
Ensembl chr 4:12,039,355...12,090,020
G
Tmem97
transmembrane protein 97
increases expression
ISO
avobenzone results in increased expression of TMEM97 mRNA
CTD
PMID:31016361
NCBI chr11:78,432,643...78,441,561
Ensembl chr11:78,432,643...78,441,603
G
Tnfrsf11b
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
multiple interactions
ISO
avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of TNFRSF11B mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased secretion of TNFRSF11B protein]
CTD
PMID:31016361
NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880
G
Tnfsf9
tumor necrosis factor (ligand) superfamily, member 9
increases expression
ISO
avobenzone results in increased expression of TNFSF9 mRNA
CTD
PMID:31016361
NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757
G
Top3b
topoisomerase (DNA) III beta
increases expression
ISO
avobenzone results in increased expression of TOP3B mRNA
CTD
PMID:31016361
NCBI chr16:16,688,587...16,710,850
Ensembl chr16:16,688,600...16,710,854
G
Traj18
T cell receptor alpha joining 18
increases expression
ISO
avobenzone results in increased expression of STK17A mRNA
CTD
PMID:31016361
NCBI chr14:54,438,234...54,438,299
Ensembl chr14:54,438,234...54,438,299
G
Traj42
T cell receptor alpha joining 42
decreases expression
ISO
avobenzone results in decreased expression of ZNF10 mRNA
CTD
PMID:31016361
NCBI chr14:54,413,230...54,413,293
Ensembl chr14:54,413,230...54,413,293
G
Tram1l1
translocation associated membrane protein 1-like 1
decreases expression
ISO
avobenzone results in decreased expression of TRAM1L1 mRNA
CTD
PMID:31016361
NCBI chr 3:124,114,686...124,116,909
Ensembl chr 3:124,114,504...124,118,392
G
Trim25
tripartite motif-containing 25
decreases expression
ISO
avobenzone results in decreased expression of TRIM25 mRNA
CTD
PMID:31016361
NCBI chr11:88,890,194...88,911,119
Ensembl chr11:88,890,202...88,911,119
G
Trim69
tripartite motif-containing 69
decreases expression
ISO
avobenzone results in decreased expression of TRIM69 mRNA
CTD
PMID:31016361
NCBI chr 2:121,991,189...122,009,503
Ensembl chr 2:121,991,181...122,009,508
G
Tsc22d3
TSC22 domain family, member 3
increases expression
ISO
avobenzone results in increased expression of TSC22D3 mRNA
CTD
PMID:31016361
NCBI chr X:139,440,277...139,501,257
Ensembl chr X:139,440,277...139,501,408
G
Tsen2
tRNA splicing endonuclease subunit 2
decreases expression
ISO
avobenzone results in decreased expression of TSEN2 mRNA
CTD
PMID:31016361
NCBI chr 6:115,521,652...115,555,297
Ensembl chr 6:115,521,625...115,555,589
G
Tspan1
tetraspanin 1
increases expression
ISO
avobenzone results in increased expression of TSPAN1 mRNA
CTD
PMID:31016361
NCBI chr 4:116,019,078...116,024,818
Ensembl chr 4:116,019,066...116,024,798
G
Tspyl5
testis-specific protein, Y-encoded-like 5
decreases expression
ISO
avobenzone results in decreased expression of TSPYL5 mRNA
CTD
PMID:31016361
NCBI chr15:33,684,021...33,688,029
Ensembl chr15:33,684,021...33,688,030
G
Ttbk2
tau tubulin kinase 2
increases expression
ISO
avobenzone results in increased expression of TTBK2 mRNA
CTD
PMID:31016361
NCBI chr 2:120,563,297...120,681,111
Ensembl chr 2:120,563,297...120,681,085
G
Ttc7b
tetratricopeptide repeat domain 7B
increases expression
ISO
avobenzone results in increased expression of TTC7B mRNA
CTD
PMID:31016361
NCBI chr12:100,267,029...100,487,134
Ensembl chr12:100,267,029...100,487,085
G
Ttc9c
tetratricopeptide repeat domain 9C
increases expression
ISO
avobenzone results in increased expression of TTC9C mRNA
CTD
PMID:31016361
NCBI chr19:8,786,430...8,797,270
Ensembl chr19:8,786,439...8,796,697
G
Tubgcp3
tubulin, gamma complex component 3
increases expression
ISO
avobenzone results in increased expression of TUBGCP3 mRNA
CTD
PMID:31016361
NCBI chr 8:12,664,277...12,722,141
Ensembl chr 8:12,664,277...12,722,248
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
avobenzone results in increased expression of TXNRD1 mRNA
CTD
PMID:31016361
NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
avobenzone results in increased expression of TXNRD2 mRNA
CTD
PMID:31016361
NCBI chr16:18,245,167...18,297,823
Ensembl chr16:18,245,134...18,297,823
G
Uqcc1
ubiquinol-cytochrome c reductase complex assembly factor 1
increases expression
ISO
avobenzone results in increased expression of UQCC1 mRNA
CTD
PMID:31016361
NCBI chr 2:155,688,806...155,772,230
Ensembl chr 2:155,688,814...155,772,230
G
Usp12
ubiquitin specific peptidase 12
increases expression
ISO
avobenzone results in increased expression of USP12 mRNA
CTD
PMID:31016361
NCBI chr 5:146,671,619...146,731,817
Ensembl chr 5:146,671,619...146,731,816
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
avobenzone results in increased expression of VEGFA protein
CTD
PMID:25617811
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
increases expression
ISO
avobenzone results in increased expression of WDHD1 mRNA
CTD
PMID:31016361
NCBI chr14:47,478,401...47,514,352
Ensembl chr14:47,478,401...47,514,314
G
Wdr5b
WD repeat domain 5B
decreases expression
ISO
avobenzone results in decreased expression of WDR5B mRNA
CTD
PMID:31016361
NCBI chr16:35,861,560...35,863,344
Ensembl chr16:35,861,560...35,864,298
G
Wfdc21
WAP four-disulfide core domain 21
decreases expression
ISO
avobenzone results in decreased expression of WFDC21P mRNA
CTD
PMID:31016361
NCBI chr11:83,637,766...83,643,472
Ensembl chr11:83,637,766...83,643,468
G
Wnt9a
wingless-type MMTV integration site family, member 9A
decreases expression
ISO
avobenzone results in decreased expression of WNT9A mRNA
CTD
PMID:31016361
NCBI chr11:59,197,675...59,224,378
Ensembl chr11:59,197,754...59,224,378
G
Xaf1
XIAP associated factor 1
decreases expression
ISO
avobenzone results in decreased expression of XAF1 mRNA
CTD
PMID:31016361
NCBI chr11:72,192,229...72,204,560
Ensembl chr11:72,192,455...72,204,559
G
Xdh
xanthine dehydrogenase
increases expression
ISO
avobenzone results in increased expression of XDH mRNA
CTD
PMID:31016361
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Xk
X-linked Kx blood group
decreases expression
ISO
avobenzone results in decreased expression of XK mRNA
CTD
PMID:31016361
NCBI chr X:9,139,023...9,179,484
Ensembl chr X:9,138,995...9,179,489
G
Zbed3
zinc finger, BED type containing 3
decreases expression
ISO
avobenzone results in decreased expression of ZBED3 mRNA
CTD
PMID:31016361
NCBI chr13:95,460,113...95,474,350
Ensembl chr13:95,460,120...95,474,349
G
Zbtb10
zinc finger and BTB domain containing 10
increases expression
ISO
avobenzone results in increased expression of ZBTB10 mRNA
CTD
PMID:31016361
NCBI chr 3:9,315,627...9,350,393
Ensembl chr 3:9,315,662...9,350,393
G
Zbtb44
zinc finger and BTB domain containing 44
increases expression
ISO
avobenzone results in increased expression of ZBTB44 mRNA
CTD
PMID:31016361
NCBI chr 9:30,941,016...30,987,181
Ensembl chr 9:30,941,940...30,987,181
G
Zdhhc21
zinc finger, DHHC domain containing 21
decreases expression
ISO
avobenzone results in decreased expression of ZDHHC21 mRNA
CTD
PMID:31016361
NCBI chr 4:82,716,975...82,778,892
Ensembl chr 4:82,716,975...82,778,195
G
Zfp112
zinc finger protein 112
decreases expression
ISO
avobenzone results in decreased expression of ZNF112 mRNA
CTD
PMID:31016361
NCBI chr 7:23,811,348...23,827,254
Ensembl chr 7:23,811,739...23,827,377
G
Zfp260
zinc finger protein 260
decreases expression
ISO
avobenzone results in decreased expression of ZNF260 mRNA
CTD
PMID:31016361
NCBI chr 7:29,794,207...29,807,047
Ensembl chr 7:29,794,202...29,807,047
G
Zfp27
zinc finger protein 27
decreases expression
ISO
avobenzone results in decreased expression of ZNF585B mRNA
CTD
PMID:31016361
NCBI chr 7:29,592,762...29,605,976
Ensembl chr 7:29,592,758...29,605,997
G
Zfp418
zinc finger protein 418
decreases expression
ISO
avobenzone results in decreased expression of ZNF416 mRNA
CTD
PMID:31016361
NCBI chr 7:7,174,352...7,186,559
Ensembl chr 7:7,174,329...7,186,561
G
Zfp518b
zinc finger protein 518B
decreases expression
ISO
avobenzone results in decreased expression of ZNF518B mRNA
CTD
PMID:31016361
NCBI chr 5:38,825,828...38,842,120
Ensembl chr 5:38,825,827...38,842,169
G
Zfp605
zinc finger protein 605
decreases expression
ISO
avobenzone results in decreased expression of ZNF605 mRNA
CTD
PMID:31016361
NCBI chr 5:110,257,898...110,279,402
Ensembl chr 5:110,257,958...110,277,660
G
Zfp606
zinc finger protein 606
decreases expression
ISO
avobenzone results in decreased expression of ZNF606 mRNA
CTD
PMID:31016361
NCBI chr 7:12,212,208...12,230,162
Ensembl chr 7:12,212,220...12,230,162
G
Zfp618
zinc finger protein 618
increases expression
ISO
avobenzone results in increased expression of ZNF618 mRNA
CTD
PMID:31016361
NCBI chr 4:62,883,792...63,057,946
Ensembl chr 4:62,883,810...63,057,945
G
Zfp623
zinc finger protein 623
decreases expression
ISO
avobenzone results in decreased expression of ZNF623 mRNA
CTD
PMID:31016361
NCBI chr15:75,812,798...75,821,251
Ensembl chr15:75,812,801...75,821,249
G
Zfp69
zinc finger protein 69
decreases expression
ISO
avobenzone results in decreased expression of ZFP69 mRNA
CTD
PMID:31016361
NCBI chr 4:120,786,201...120,808,898
Ensembl chr 4:120,787,334...120,808,896
G
Zfp74
zinc finger protein 74
increases expression
ISO
avobenzone results in increased expression of ZNF569 mRNA
CTD
PMID:31016361
NCBI chr 7:29,632,086...29,653,579
Ensembl chr 7:29,630,240...29,653,514
G
Zfp747l1
zinc finger protein 747 like 1
decreases expression
ISO
avobenzone results in decreased expression of ZNF554 mRNA
CTD
PMID:31016361
NCBI chr 7:126,981,432...126,986,338
Ensembl chr 7:126,981,432...126,986,338
G
Zfp870
zinc finger protein 870
increases expression
ISO
avobenzone results in increased expression of ZNF670 mRNA
CTD
PMID:31016361
NCBI chr17:33,098,193...33,110,621
Ensembl chr17:33,098,193...33,110,616
G
Zfp879
zinc finger protein 879
decreases expression
ISO
avobenzone results in decreased expression of ZNF879 mRNA
CTD
PMID:31016361
NCBI chr11:50,719,821...50,732,414
Ensembl chr11:50,722,858...50,732,379
G
Zfp961
zinc finger protein 961
decreases expression
ISO
avobenzone results in decreased expression of ZNF844 mRNA
CTD
PMID:31016361
NCBI chr 8:72,704,910...72,724,177
Ensembl chr 8:72,704,882...72,747,636
G
Zscan26
zinc finger and SCAN domain containing 26
decreases expression
ISO
avobenzone results in decreased expression of ZSCAN26 mRNA
CTD
PMID:31016361
NCBI chr13:21,626,344...21,637,901
Ensembl chr13:21,626,350...21,637,900
G
Zscan29
zinc finger SCAN domains 29
decreases expression
ISO
avobenzone results in decreased expression of ZSCAN29 mRNA
CTD
PMID:31016361
NCBI chr 2:120,988,754...121,001,623
Ensembl chr 2:120,988,754...121,001,606
G
Casp3
caspase 3
multiple interactions
EXP
neohesperidin dihydrochalcone inhibits the reaction [Carbon Tetrachloride results in increased expression of CASP3 protein]
CTD
PMID:24530446
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
multiple interactions
EXP
neohesperidin dihydrochalcone inhibits the reaction [Carbon Tetrachloride results in increased expression of CASP8 protein]
CTD
PMID:24530446
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cat
catalase
multiple interactions
EXP
neohesperidin dihydrochalcone inhibits the reaction [Carbon Tetrachloride results in decreased expression of CAT protein]
CTD
PMID:24530446
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Gpt
glutamic pyruvic transaminase, soluble
multiple interactions
EXP
neohesperidin dihydrochalcone inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]
CTD
PMID:24530446
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Il6
interleukin 6
multiple interactions
EXP
neohesperidin dihydrochalcone inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 protein]
CTD
PMID:24530446
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
EXP
neohesperidin dihydrochalcone inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]
CTD
PMID:24530446
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
neohesperidin dihydrochalcone inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein]
CTD
PMID:24530446
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Tas1r2
taste receptor, type 1, member 2
multiple interactions
ISO
lactisole inhibits the reaction [neohesperidin dihydrochalcone results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]]; neohesperidin dihydrochalcone results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]
CTD
PMID:17935609
NCBI chr 4:139,380,849...139,397,591
Ensembl chr 4:139,380,849...139,397,591
G
Tas1r3
taste receptor, type 1, member 3
multiple interactions affects binding
ISO
lactisole inhibits the reaction [neohesperidin dihydrochalcone results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]]; neohesperidin dihydrochalcone binds to and results in increased activity of TAS1R3 protein; neohesperidin dihydrochalcone results in increased activity of [TAS1R3 protein binds to TAS1R2 protein] neohesperidin dihydrochalcone binds to TAS1R3 protein
CTD
PMID:17935609 PMID:20173092
NCBI chr 4:155,943,725...155,947,810
Ensembl chr 4:155,943,725...155,947,819
G
Ache
acetylcholinesterase
multiple interactions
EXP
[[sodium arsenite results in increased abundance of Arsenic] which co-treated with Phloretin] results in increased activity of ACHE protein
CTD
PMID:33410021
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of ADIPOQ mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of ADIPOQ mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of ADIPOQ mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in decreased secretion of ADIPOQ protein]]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of ADIPOQ mRNA; [cobaltous chloride co-treated with Phloretin] affects the expression of ADIPOQ mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of ADIPOQ mRNA; Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in decreased secretion of ADIPOQ protein]
CTD
PMID:32408695
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Afp
alpha fetoprotein
affects binding
ISO
Phloretin binds to AFP protein
CTD
PMID:23013281 PMID:25349334
NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
G
Akt1
thymoma viral proto-oncogene 1
multiple interactions
ISO
[Ruthenium binds to Phloretin] which results in decreased expression of AKT1 protein Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of AKT1 mRNA]
CTD
PMID:34037972 PMID:34896434
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Angptl4
angiopoietin-like 4
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of ANGPTL4 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of ANGPTL4 mRNA]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of ANGPTL4 mRNA; [cobaltous chloride co-treated with Phloretin] affects the expression of ANGPTL4 mRNA
CTD
PMID:32408695
NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
G
Aqp9
aquaporin 9
multiple interactions decreases activity
ISO
Phloretin inhibits the reaction [AQP9 protein results in increased transport of Water]; Phloretin inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]] Phloretin inhibits the reaction [AQP9 protein results in increased uptake of Lactic Acid]; Phloretin inhibits the reaction [AQP9 protein results in increased uptake of Selenic Acid analog]; Phloretin inhibits the reaction [AQP9 protein results in increased uptake of Selenious Acid] Phloretin results in decreased activity of AQP9 protein
CTD
PMID:9733774 PMID:12606488 PMID:21259319 PMID:28798983
NCBI chr 9:71,017,941...71,075,170
Ensembl chr 9:71,017,941...71,075,964
G
Bad
BCL2-associated agonist of cell death
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BAD protein]]; Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BAD protein]
CTD
PMID:32408695
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bax
BCL2-associated X protein
multiple interactions
ISO
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]
CTD
PMID:34037972 PMID:34896434
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bche
butyrylcholinesterase
multiple interactions
EXP
Phloretin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of BCHE protein]
CTD
PMID:33410021
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Bcl2
B cell leukemia/lymphoma 2
multiple interactions
ISO
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]
CTD
PMID:34037972 PMID:34896434
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of BCL2L1 protein]]; Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of BCL2L1 protein]
CTD
PMID:32408695
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bcl2l11
BCL2 like 11
multiple interactions
EXP
Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BCL2L11 protein]
CTD
PMID:32408695
NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
G
Casp3
caspase 3
multiple interactions
ISO
[Ruthenium binds to Phloretin] which results in increased cleavage of CASP3 protein
CTD
PMID:34896434
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp9
caspase 9
multiple interactions
ISO
[Ruthenium binds to Phloretin] which results in decreased expression of and results in increased cleavage of CASP9 protein
CTD
PMID:34896434
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cat
catalase
multiple interactions
ISO
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein]
CTD
PMID:34896434
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cav3
caveolin 3
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of CAV3 mRNA]
CTD
PMID:34037972
NCBI chr 6:112,436,466...112,449,833
Ensembl chr 6:112,436,466...112,449,833
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO EXP
Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of CCL2 protein] 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of CCL2 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of CCL2 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of CCL2 mRNA]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of CCL2 mRNA; [cobaltous chloride co-treated with Phloretin] affects the expression of CCL2 mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of CCL2 mRNA
CTD
PMID:24707119 PMID:32408695 PMID:34037972
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein]
CTD
PMID:24707119
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
multiple interactions
ISO
[Ruthenium binds to Phloretin] which results in increased expression of CDKN1A protein
CTD
PMID:34896434
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cftr
cystic fibrosis transmembrane conductance regulator
multiple interactions
ISO
Phloretin inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]]
CTD
PMID:12606488
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Csf3
colony stimulating factor 3 (granulocyte)
multiple interactions
ISO
Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of CSF3 protein]
CTD
PMID:24707119
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
Phloretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Phloretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Phloretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]
CTD
PMID:17177569
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Des
desmin
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of DES mRNA]
CTD
PMID:34037972
NCBI chr 1:75,336,936...75,345,223
Ensembl chr 1:75,336,973...75,345,223
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
[Ruthenium binds to Phloretin] which results in decreased expression of EGFR protein
CTD
PMID:34896434
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
Phloretin binds to and results in increased activity of ESR1 protein
CTD
PMID:9751507
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
multiple interactions affects binding
ISO
Phloretin binds to and results in increased activity of ESR2 protein Phloretin binds to ESR2 protein
CTD
PMID:9751507 PMID:12224631
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Gpt
glutamic pyruvic transaminase, soluble
multiple interactions
EXP
Phloretin inhibits the reaction [Acetaminophen results in increased activity of GPT protein]
CTD
PMID:30287234
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gsk3b
glycogen synthase kinase 3 beta
decreases activity
ISO
Phloretin results in decreased activity of GSK3B protein
CTD
PMID:16968061
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Hif1a
hypoxia inducible factor 1, alpha subunit
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of HIF1A mRNA]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of HIF1A mRNA
CTD
PMID:32408695
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Ifng
interferon gamma
multiple interactions
ISO
Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein] Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of IFNG protein]
CTD
PMID:24707119 PMID:34037972
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of IGF1 mRNA]
CTD
PMID:34037972
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Il10
interleukin 10
multiple interactions
ISO
Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein] Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of IL10 protein]
CTD
PMID:24707119 PMID:34037972
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1A protein]
CTD
PMID:24707119
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
multiple interactions
ISO EXP
Phloretin inhibits the reaction [Uric Acid results in increased secretion of IL1B protein] 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of IL1B mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of IL1B mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of IL1B mRNA]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of IL1B mRNA; [cobaltous chloride co-treated with Phloretin] affects the expression of IL1B mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of IL1B mRNA
CTD
PMID:21051542 PMID:32408695
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
ISO
Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1RN protein]
CTD
PMID:24707119
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il2
interleukin 2
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of IL2 protein]
CTD
PMID:34037972
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il6
interleukin 6
multiple interactions
ISO EXP
Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein] 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of IL6 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of IL6 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of IL6 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL6 protein]]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of IL6 mRNA; [cobaltous chloride co-treated with Phloretin] affects the expression of IL6 mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of IL6 mRNA; Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL6 protein]
CTD
PMID:24707119 PMID:32408695 PMID:34037972
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Ins2
insulin II
multiple interactions
ISO
Phloretin inhibits the reaction [[chromic chloride results in increased activity of INS protein modified form] which results in increased secretion of Adenosine Triphosphate]
CTD
PMID:17965850
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
G
Kcnma1
potassium large conductance calcium-activated channel, subfamily M, alpha member 1
affects response to substance
ISO
KCNMA1 mRNA affects the susceptibility to Phloretin
CTD
PMID:19247476
NCBI chr14:23,342,356...24,055,173
Ensembl chr14:23,339,499...24,064,559
G
Lep
leptin
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of LEP mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of LEP mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of LEP mRNA]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of LEP mRNA; [cobaltous chloride co-treated with Phloretin] affects the expression of LEP mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] affects the expression of LEP mRNA; Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of LEP protein]
CTD
PMID:32408695
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Ltf
lactotransferrin
increases expression
ISO
Phloretin results in increased expression of LTF protein
CTD
PMID:24487097
NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of MAPK1 mRNA]
CTD
PMID:34037972
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of MAPK3 mRNA]
CTD
PMID:34037972
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of MAPK8 mRNA]
CTD
PMID:34037972
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mki67
antigen identified by monoclonal antibody Ki 67
multiple interactions
ISO
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]
CTD
PMID:34896434
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]
CTD
PMID:34896434
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
[Ruthenium binds to Phloretin] which results in decreased expression of MTOR protein
CTD
PMID:34896434
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Nfatc1
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of NFATC1 mRNA]; Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of NFATC1 protein]
CTD
PMID:34037972
NCBI chr18:80,649,418...80,756,286
Ensembl chr18:80,649,420...80,756,286
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
multiple interactions
EXP
[[sodium arsenite results in increased abundance of Arsenic] which co-treated with Phloretin] results in increased expression of NFE2L2 mRNA
CTD
PMID:33410021
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of NFKB1 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of NFKB1 mRNA]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of NFKB1 mRNA; [cobaltous chloride co-treated with Phloretin] affects the expression of NFKB1 mRNA
CTD
PMID:32408695
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nos3
nitric oxide synthase 3, endothelial cell
decreases expression multiple interactions
ISO
Phloretin results in decreased expression of NOS3 mRNA Phloretin inhibits the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA]
CTD
PMID:20021702
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of PPARG mRNA]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of PPARG mRNA; [cobaltous chloride co-treated with Phloretin] affects the expression of PPARG mRNA
CTD
PMID:32408695
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppp3ca
protein phosphatase 3, catalytic subunit, alpha isoform
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of PPP3CA protein]
CTD
PMID:34037972
NCBI chr 3:136,375,778...136,643,488
Ensembl chr 3:136,375,885...136,643,488
G
Raf1
v-raf-leukemia viral oncogene 1
multiple interactions
ISO
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of RAF1 mRNA]
CTD
PMID:34037972
NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
EXP ISO
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased phosphorylation of RELA protein]]; Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased phosphorylation of RELA protein] Phloretin inhibits the reaction [Arsenic Trioxide affects the localization of RELA protein]
CTD
PMID:32408695 PMID:34037972
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Shbg
sex hormone binding globulin
affects binding
ISO
Phloretin binds to SHBG protein
CTD
PMID:25349334
NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731
G
Slc14a1
solute carrier family 14 (urea transporter), member 1
multiple interactions
ISO
Phloretin inhibits the reaction [SLC14A1 protein results in increased transport of Urea]
CTD
PMID:8982255
NCBI chr18:78,143,306...78,185,334
Ensembl chr18:78,143,306...78,185,334
G
Slc14a2
solute carrier family 14 (urea transporter), member 2
multiple interactions
ISO
Phloretin inhibits the reaction [SLC14A2 protein results in increased transport of Urea]
CTD
PMID:11181411
NCBI chr18:78,189,359...78,640,165
Ensembl chr18:78,189,363...78,640,157
G
Slc16a1
solute carrier family 16 (monocarboxylic acid transporters), member 1
multiple interactions
ISO
[[Luteolin co-treated with Phloretin] results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate; [Phloretin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate
CTD
PMID:17108059
NCBI chr 3:104,545,980...104,565,778
Ensembl chr 3:104,545,984...104,565,778
G
Slc16a2
solute carrier family 16 (monocarboxylic acid transporters), member 2
multiple interactions
ISO
Phloretin inhibits the reaction [SLC16A2 protein results in increased uptake of Triiodothyronine]
CTD
PMID:28119167
NCBI chr X:102,741,020...102,865,594
Ensembl chr X:102,741,020...102,865,589
G
Slc2a1
solute carrier family 2 (facilitated glucose transporter), member 1
multiple interactions decreases activity
ISO
Phloretin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] Phloretin results in decreased activity of SLC2A1 protein
CTD
PMID:14642735
NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
multiple interactions decreases expression
EXP ISO
Phloretin inhibits the reaction [Fluorouracil promotes the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]]; Phloretin inhibits the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose] Phloretin results in decreased expression of SLC2A2 protein Phloretin inhibits the reaction [SLC2A2 protein results in increased uptake of Glucose]
CTD
PMID:15986457 PMID:17272349 PMID:26616219
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
G
Slc2a9
solute carrier family 2 (facilitated glucose transporter), member 9
multiple interactions
EXP
Phloretin inhibits the reaction [SLC2A9 protein results in increased uptake of Uric Acid]
CTD
PMID:19587147
NCBI chr 5:38,506,616...38,660,488
Ensembl chr 5:38,506,616...38,660,486
G
Slc9a1
solute carrier family 9 (sodium/hydrogen exchanger), member 1
multiple interactions decreases activity
ISO
Phloretin inhibits the reaction [SLC9A1 protein alternative form affects the transport of [Sodium co-treated with Lithium]] Phloretin results in decreased activity of SLC9A1 protein; Phloretin results in decreased activity of SLC9A1 protein alternative form
CTD
PMID:12765964
NCBI chr 4:133,097,022...133,151,013
Ensembl chr 4:133,097,017...133,151,013
G
Slc9b2
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2
decreases activity
ISO
Phloretin results in decreased activity of SLC9B2 protein
CTD
PMID:18000046
NCBI chr 3:135,013,083...135,048,606
Ensembl chr 3:135,013,461...135,051,148
G
Tnf
tumor necrosis factor
multiple interactions
EXP ISO
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of TNF mRNA]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of TNF mRNA Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of TNF protein]
CTD
PMID:32408695 PMID:34037972
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trp53
transformation related protein 53
multiple interactions
ISO
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TP53 protein] [Ruthenium binds to Phloretin] which results in increased expression of TP53 protein
CTD
PMID:34896434
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
decreases activity
ISO
Phloretin results in decreased activity of UGT1A1 protein
CTD
PMID:35868516
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Ugt1a10
UDP glycosyltransferase 1 family, polypeptide A10
increases glucuronidation decreases activity
ISO
UGT1A10 protein results in increased glucuronidation of Phloretin Phloretin results in decreased activity of UGT1A10 protein
CTD
PMID:14557274 PMID:35868516
NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
decreases activity
ISO
Phloretin results in decreased activity of UGT1A3 protein
CTD
PMID:35868516
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
G
Ugt1a6b
UDP glucuronosyltransferase 1 family, polypeptide A6B
decreases activity
ISO
Phloretin results in decreased activity of UGT1A6 protein
CTD
PMID:35868516
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
G
Ugt1a9
UDP glucuronosyltransferase 1 family, polypeptide A9
decreases activity
ISO
Phloretin results in decreased activity of UGT1A9 protein
CTD
PMID:35868516
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
decreases activity
ISO
Phloretin results in decreased activity of UGT2B17 protein
CTD
PMID:35868516
NCBI chr 5:87,064,498...87,074,362
Ensembl chr 5:87,064,497...87,074,389
G
Ugt2b34
UDP glucuronosyltransferase 2 family, polypeptide B34
decreases activity
ISO
Phloretin results in decreased activity of UGT2B7 protein
CTD
PMID:35868516
NCBI chr 5:87,037,613...87,054,805
Ensembl chr 5:87,037,626...87,054,796
G
Vegfa
vascular endothelial growth factor A
multiple interactions
EXP ISO
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of VEGFA mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of VEGFA mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Phloretin promotes the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of VEGFA protein]]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of VEGFA mRNA; [cobaltous chloride co-treated with Phloretin] affects the expression of VEGFA mRNA; Phloretin promotes the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of VEGFA protein] [Ruthenium binds to Phloretin] which results in decreased expression of VEGFA protein
CTD
PMID:32408695 PMID:34896434
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Abat
4-aminobutyrate aminotransferase
decreases expression
EXP
Phlorhizin results in decreased expression of ABAT mRNA
CTD
PMID:22538082
NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432
G
Acaa1b
acetyl-Coenzyme A acyltransferase 1B
increases expression
EXP
Phlorhizin results in increased expression of ACAA1 mRNA
CTD
PMID:22538082
NCBI chr 9:118,977,111...118,986,149
Ensembl chr 9:118,977,091...118,986,161
G
Acaa2
acetyl-CoA acyltransferase 2
decreases expression
EXP
Phlorhizin results in decreased expression of ACAA2 mRNA
CTD
PMID:22538082
NCBI chr18:74,912,283...74,939,278
Ensembl chr18:74,912,268...74,939,279
G
Acad8
acyl-Coenzyme A dehydrogenase family, member 8
decreases expression
EXP
Phlorhizin results in decreased expression of ACAD8 mRNA
CTD
PMID:22538082
NCBI chr 9:26,885,434...26,910,872
Ensembl chr 9:26,885,431...26,910,862
G
Acad9
acyl-Coenzyme A dehydrogenase family, member 9
decreases expression
EXP
Phlorhizin results in decreased expression of ACAD9 mRNA
CTD
PMID:22538082
NCBI chr 3:36,120,128...36,147,006
Ensembl chr 3:36,120,128...36,147,002
G
Acadl
acyl-Coenzyme A dehydrogenase, long-chain
decreases expression
EXP
Phlorhizin results in decreased expression of ACADL mRNA
CTD
PMID:22538082
NCBI chr 1:66,869,998...66,902,468
Ensembl chr 1:66,869,998...66,902,436
G
Acadm
acyl-Coenzyme A dehydrogenase, medium chain
decreases expression
EXP
Phlorhizin results in decreased expression of ACADM mRNA
CTD
PMID:22538082
NCBI chr 3:153,627,990...153,650,280
Ensembl chr 3:153,627,994...153,650,269
G
Acat1
acetyl-Coenzyme A acetyltransferase 1
decreases expression
EXP
Phlorhizin results in decreased expression of ACAT1 mRNA
CTD
PMID:22538082
NCBI chr 9:53,491,822...53,521,650
Ensembl chr 9:53,491,822...53,521,682
G
Aco1
aconitase 1
decreases expression
EXP
Phlorhizin results in decreased expression of ACO1 mRNA
CTD
PMID:22538082
NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338
G
Acox1
acyl-Coenzyme A oxidase 1, palmitoyl
decreases expression
EXP
Phlorhizin results in decreased expression of ACOX1 mRNA
CTD
PMID:22538082
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
G
Acox2
acyl-Coenzyme A oxidase 2, branched chain
decreases expression
EXP
Phlorhizin results in decreased expression of ACOX2 mRNA
CTD
PMID:22538082
NCBI chr14:14,210,406...14,244,262
Ensembl chr14:14,210,420...14,244,262
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
EXP
Phlorhizin results in decreased expression of ACSL1 mRNA
CTD
PMID:22538082
NCBI chr 8:46,924,214...46,989,088
Ensembl chr 8:46,924,074...46,989,088
G
Actb
actin, beta
increases expression
EXP
Phlorhizin results in increased expression of ACTB mRNA
CTD
PMID:22538082
NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
G
Adh5
alcohol dehydrogenase 5 (class III), chi polypeptide
decreases expression
EXP
Phlorhizin results in decreased expression of ADH5 mRNA
CTD
PMID:22538082
NCBI chr 3:138,142,961...138,161,260
Ensembl chr 3:138,148,854...138,161,260
G
Adhfe1
alcohol dehydrogenase, iron containing, 1
decreases expression
EXP
Phlorhizin results in decreased expression of ADHFE1 mRNA
CTD
PMID:22538082
NCBI chr 1:9,618,173...9,648,195
Ensembl chr 1:9,618,173...9,650,898
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phlorhizin] affects the expression of ADIPOQ mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] affects the expression of ADIPOQ mRNA]; [cobaltous chloride co-treated with Phlorhizin] affects the expression of ADIPOQ mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] affects the expression of ADIPOQ mRNA
CTD
PMID:32408695
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Akr1a1
aldo-keto reductase family 1, member A1
decreases expression
EXP
Phlorhizin results in decreased expression of AKR1A1 mRNA
CTD
PMID:22538082
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Akr7a5
aldo-keto reductase family 7, member A5
increases expression
EXP
Phlorhizin results in increased expression of AKR7A2 mRNA
CTD
PMID:22538082
NCBI chr 4:139,038,005...139,046,097
Ensembl chr 4:139,038,055...139,045,737
G
Alb
albumin
multiple interactions
ISO
Phlorhizin inhibits the reaction [Glucose results in decreased uptake of ALB protein]
CTD
PMID:16313995
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aldh1a7
aldehyde dehydrogenase family 1, subfamily A7
decreases expression
EXP
Phlorhizin results in decreased expression of ALDH1A7 mRNA
CTD
PMID:22538082
NCBI chr19:20,670,318...20,704,920
Ensembl chr19:20,670,317...20,704,926
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
decreases expression increases expression
EXP
Phlorhizin results in decreased expression of ALDH2 mRNA Phlorhizin results in increased expression of ALDH2 mRNA
CTD
PMID:22538082
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Aldh3a2
aldehyde dehydrogenase family 3, subfamily A2
decreases expression
EXP
Phlorhizin results in decreased expression of ALDH3A2 mRNA
CTD
PMID:22538082
NCBI chr11:61,114,240...61,158,267
Ensembl chr11:61,114,243...61,158,290
G
Aldh4a1
aldehyde dehydrogenase 4 family, member A1
decreases expression
EXP
Phlorhizin results in decreased expression of ALDH4A1 mRNA
CTD
PMID:22538082
NCBI chr 4:139,348,404...139,377,002
Ensembl chr 4:139,350,177...139,377,001
G
Aldh6a1
aldehyde dehydrogenase family 6, subfamily A1
decreases expression
EXP
Phlorhizin results in decreased expression of ALDH6A1 mRNA
CTD
PMID:22538082
NCBI chr12:84,477,491...84,497,798
Ensembl chr12:84,477,491...84,497,778
G
Aldh7a1
aldehyde dehydrogenase family 7, member A1
decreases expression
EXP
Phlorhizin results in decreased expression of ALDH7A1 mRNA
CTD
PMID:22538082
NCBI chr18:56,657,794...56,706,112
Ensembl chr18:56,642,759...56,706,023
G
Anapc2
anaphase promoting complex subunit 2
decreases expression
EXP
Phlorhizin results in decreased expression of ANAPC2 mRNA
CTD
PMID:22538082
NCBI chr 2:25,162,469...25,175,928
Ensembl chr 2:25,162,490...25,175,927
G
Anapc5
anaphase-promoting complex subunit 5
decreases expression
EXP
Phlorhizin results in decreased expression of ANAPC5 mRNA
CTD
PMID:22538082
NCBI chr 5:122,925,522...122,960,402
Ensembl chr 5:122,925,522...122,959,402
G
Aox1
aldehyde oxidase 1
decreases expression
EXP
Phlorhizin results in decreased expression of AOX1 mRNA
CTD
PMID:22538082
NCBI chr 1:58,068,963...58,145,569
Ensembl chr 1:58,069,090...58,145,572
G
Aox3
aldehyde oxidase 3
decreases expression
EXP
Phlorhizin results in decreased expression of AOX3 mRNA
CTD
PMID:22538082
NCBI chr 1:58,152,294...58,241,380
Ensembl chr 1:58,152,289...58,239,857
G
Aph1b
aph1 homolog B, gamma secretase subunit
increases expression
EXP
Phlorhizin results in increased expression of APH1B mRNA
CTD
PMID:22538082
NCBI chr 9:66,682,484...66,704,671
Ensembl chr 9:66,682,484...66,702,772
G
App
amyloid beta precursor protein
decreases expression
EXP
Phlorhizin results in decreased expression of APP mRNA
CTD
PMID:22538082
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Atf3
activating transcription factor 3
decreases expression
EXP
Phlorhizin results in decreased expression of ATF3 mRNA
CTD
PMID:16123366
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
G
Atp2a2
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
increases expression
EXP
Phlorhizin results in increased expression of ATP2A2 mRNA
CTD
PMID:16123366
NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
G
Atp5f1a
ATP synthase F1 subunit alpha
decreases expression
EXP
Phlorhizin results in decreased expression of ATP5F1A mRNA
CTD
PMID:22538082
NCBI chr18:77,861,468...77,870,569
Ensembl chr18:77,861,429...77,870,569
G
Atp5f1c
ATP synthase F1 subunit gamma
increases expression
EXP
Phlorhizin results in increased expression of ATP5F1C mRNA
CTD
PMID:22538082
NCBI chr 2:10,060,841...10,085,321
Ensembl chr 2:10,060,827...10,085,321
G
Auh
AU RNA binding protein/enoyl-coenzyme A hydratase
decreases expression
EXP
Phlorhizin results in decreased expression of AUH mRNA
CTD
PMID:22538082
NCBI chr13:52,989,155...53,083,742
Ensembl chr13:52,989,155...53,083,717
G
B2m
beta-2 microglobulin
increases expression
EXP
Phlorhizin results in increased expression of B2M mRNA
CTD
PMID:22538082
NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564
G
Bad
BCL2-associated agonist of cell death
multiple interactions
EXP
[2,2-bis(4-glycidyloxyphenyl)propane co-treated with Phlorhizin] promotes the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BAD protein]
CTD
PMID:32408695
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bag1
BCL2-associated athanogene 1
decreases expression
EXP
Phlorhizin results in decreased expression of BAG1 mRNA
CTD
PMID:22538082
NCBI chr 4:40,936,398...40,948,294
Ensembl chr 4:40,936,398...40,948,294
G
Bckdhb
branched chain ketoacid dehydrogenase E1, beta polypeptide
decreases expression
EXP
Phlorhizin results in decreased expression of BCKDHB mRNA
CTD
PMID:22538082
NCBI chr 9:83,807,190...84,006,293
Ensembl chr 9:83,807,198...84,006,293
G
Bcl2l1
BCL2-like 1
multiple interactions
EXP
[2,2-bis(4-glycidyloxyphenyl)propane co-treated with Phlorhizin] promotes the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of BCL2L1 protein]
CTD
PMID:32408695
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Birc6
baculoviral IAP repeat-containing 6
increases expression
EXP
Phlorhizin results in increased expression of BIRC6 mRNA
CTD
PMID:22538082
NCBI chr17:74,835,247...75,010,351
Ensembl chr17:74,835,290...75,010,351
G
Cat
catalase
increases expression
EXP
Phlorhizin results in increased expression of CAT mRNA
CTD
PMID:22538082
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phlorhizin] affects the expression of CCL2 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] affects the expression of CCL2 mRNA]; [cobaltous chloride co-treated with Phlorhizin] affects the expression of CCL2 mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] affects the expression of CCL2 mRNA
CTD
PMID:32408695
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Cct7
chaperonin containing TCP1 subunit 7
decreases expression
EXP
Phlorhizin results in decreased expression of CCT7 mRNA
CTD
PMID:22538082
NCBI chr 6:85,428,487...85,445,459
Ensembl chr 6:85,428,496...85,445,457
G
Chrm2
cholinergic receptor, muscarinic 2, cardiac
multiple interactions
ISO
Phlorhizin inhibits the reaction [Streptozocin results in increased expression of CHRM2 mRNA]; Phlorhizin inhibits the reaction [Streptozocin results in increased expression of CHRM2 protein]
CTD
PMID:18715473
NCBI chr 6:36,364,928...36,505,573
Ensembl chr 6:36,365,019...36,505,349
G
Clybl
citrate lyase beta like
decreases expression
EXP
Phlorhizin results in decreased expression of CLYBL mRNA
CTD
PMID:22538082
NCBI chr14:122,408,289...122,639,646
Ensembl chr14:122,419,116...122,639,646
G
Cox15
cytochrome c oxidase assembly protein 15
decreases expression
EXP
Phlorhizin results in decreased expression of COX15 mRNA
CTD
PMID:22538082
NCBI chr19:43,721,693...43,741,439
Ensembl chr19:43,721,693...43,741,439
G
Cox17
cytochrome c oxidase assembly protein 17, copper chaperone
decreases expression
EXP
Phlorhizin results in decreased expression of COX17 mRNA
CTD
PMID:22538082
NCBI chr16:38,167,332...38,173,125
Ensembl chr16:38,167,353...38,182,659
G
Cox7c
cytochrome c oxidase subunit 7C
increases expression
EXP
Phlorhizin results in increased expression of COX7C mRNA
CTD
PMID:22538082
NCBI chr13:86,192,917...86,194,914
Ensembl chr13:86,192,935...86,195,023
G
Cox8a
cytochrome c oxidase subunit 8A
decreases expression
EXP
Phlorhizin results in decreased expression of COX8A mRNA
CTD
PMID:22538082
NCBI chr19:7,192,523...7,194,981
Ensembl chr19:7,192,518...7,194,981
G
Cpt1a
carnitine palmitoyltransferase 1a, liver
decreases expression
EXP
Phlorhizin results in decreased expression of CPT1A mRNA
CTD
PMID:16123366 PMID:22538082
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
G
Cpt2
carnitine palmitoyltransferase 2
decreases expression
EXP
Phlorhizin results in decreased expression of CPT2 mRNA
CTD
PMID:22538082
NCBI chr 4:107,761,179...107,780,786
Ensembl chr 4:107,761,178...107,780,807
G
Crebbp
CREB binding protein
decreases expression
EXP
Phlorhizin results in decreased expression of CREBBP mRNA
CTD
PMID:22538082
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
G
Cs
citrate synthase
decreases expression
EXP
Phlorhizin results in decreased expression of CS mRNA
CTD
PMID:22538082
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
G
Cul1
cullin 1
decreases expression
EXP
Phlorhizin results in decreased expression of CUL1 mRNA
CTD
PMID:22538082
NCBI chr 6:47,430,516...47,503,078
Ensembl chr 6:47,430,332...47,503,073
G
Cyb5r3
cytochrome b5 reductase 3
decreases expression
EXP
Phlorhizin results in decreased expression of CYB5R3 mRNA
CTD
PMID:22538082
NCBI chr15:83,037,696...83,060,641
Ensembl chr15:83,037,695...83,056,793
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases expression
EXP
Phlorhizin results in decreased expression of CYP1A2 mRNA
CTD
PMID:22538082
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
decreases expression
EXP
Phlorhizin results in decreased expression of CYP2B6 mRNA
CTD
PMID:22538082
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2d13
cytochrome P450, family 2, subfamily d, polypeptide 13
decreases expression
EXP
Phlorhizin results in decreased expression of CYP2D13 mRNA
CTD
PMID:22538082
NCBI chr15:82,520,951...82,526,246
Ensembl chr15:82,520,388...82,526,247
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
increases expression
EXP
Phlorhizin results in increased expression of CYP2D6 mRNA
CTD
PMID:22538082
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Cyp2j5
cytochrome P450, family 2, subfamily j, polypeptide 5
decreases expression
EXP
Phlorhizin results in decreased expression of CYP2J5 mRNA
CTD
PMID:22538082
NCBI chr 4:96,517,010...96,552,391
Ensembl chr 4:96,517,010...96,552,391
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
decreases expression increases expression
EXP
Phlorhizin results in decreased expression of CYP3A7 mRNA Phlorhizin results in increased expression of CYP3A7 mRNA
CTD
PMID:22538082
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Cyp4a10
cytochrome P450, family 4, subfamily a, polypeptide 10
increases expression
EXP
Phlorhizin results in increased expression of CYP4A11 mRNA
CTD
PMID:22538082
NCBI chr 4:115,375,484...115,390,846
Ensembl chr 4:115,375,461...115,390,846
G
Cyp4f14
cytochrome P450, family 4, subfamily f, polypeptide 14
decreases expression
EXP
Phlorhizin results in decreased expression of CYP4F12 mRNA
CTD
PMID:22538082
NCBI chr17:33,122,331...33,136,353
Ensembl chr17:33,124,044...33,136,316
G
Dhrs4
dehydrogenase/reductase 4
decreases expression
EXP
Phlorhizin results in decreased expression of DHRS4 mRNA
CTD
PMID:22538082
NCBI chr14:55,715,880...55,727,797
Ensembl chr14:55,716,215...55,727,797
G
Dld
dihydrolipoamide dehydrogenase
decreases expression
EXP
Phlorhizin results in decreased expression of DLD mRNA
CTD
PMID:22538082
NCBI chr12:31,381,561...31,401,470
Ensembl chr12:31,381,276...31,401,452
G
Dnaja2
DnaJ heat shock protein family (Hsp40) member A2
decreases expression
EXP
Phlorhizin results in decreased expression of DNAJA2 mRNA
CTD
PMID:22538082
NCBI chr 8:86,264,262...86,281,990
Ensembl chr 8:86,264,262...86,281,973
G
Dnaja3
DnaJ heat shock protein family (Hsp40) member A3
decreases expression
EXP
Phlorhizin results in decreased expression of DNAJA3 mRNA
CTD
PMID:22538082
NCBI chr16:4,501,934...4,525,559
Ensembl chr16:4,457,853...4,525,559
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
decreases expression increases expression
EXP
Phlorhizin results in decreased expression of DNAJB1 mRNA Phlorhizin results in increased expression of DNAJB1 mRNA
CTD
PMID:22538082
NCBI chr 8:84,334,804...84,339,282
Ensembl chr 8:84,334,822...84,339,282
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression
EXP
Phlorhizin results in decreased expression of DNAJB4 mRNA
CTD
PMID:22538082
NCBI chr 3:151,887,217...151,915,720
Ensembl chr 3:151,884,148...151,915,939
G
Dnajb6
DnaJ heat shock protein family (Hsp40) member B6
increases expression
EXP
Phlorhizin results in increased expression of DNAJB6 mRNA
CTD
PMID:22538082
NCBI chr 5:29,940,896...29,991,476
Ensembl chr 5:29,940,686...30,023,132
G
Dnajc1
DnaJ heat shock protein family (Hsp40) member C1
decreases expression
EXP
Phlorhizin results in decreased expression of DNAJC1 mRNA
CTD
PMID:22538082
NCBI chr 2:18,210,445...18,402,025
Ensembl chr 2:18,200,465...18,397,641
G
Dnajc13
DnaJ heat shock protein family (Hsp40) member C13
decreases expression
EXP
Phlorhizin results in decreased expression of DNAJC13 mRNA
CTD
PMID:22538082
NCBI chr 9:104,028,796...104,140,807
Ensembl chr 9:104,028,481...104,140,129
G
Dnajc14
DnaJ heat shock protein family (Hsp40) member C14
increases expression
EXP
Phlorhizin results in increased expression of DNAJC14 mRNA
CTD
PMID:22538082
NCBI chr10:128,641,423...128,655,317
Ensembl chr10:128,639,931...128,655,315
G
Dnajc19
DnaJ heat shock protein family (Hsp40) member C19
decreases expression
EXP
Phlorhizin results in decreased expression of DNAJC19 mRNA
CTD
PMID:22538082
NCBI chr 3:34,111,429...34,135,503
Ensembl chr 3:34,110,169...34,135,470
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
decreases expression
EXP
Phlorhizin results in decreased expression of DNAJC3 mRNA
CTD
PMID:22538082
NCBI chr14:119,175,371...119,219,114
Ensembl chr14:119,175,388...119,219,109
G
Dnajc4
DnaJ heat shock protein family (Hsp40) member C4
increases expression
EXP
Phlorhizin results in increased expression of DNAJC4 mRNA
CTD
PMID:22538082
NCBI chr19:6,965,279...6,969,954
Ensembl chr19:6,965,279...6,969,940
G
Dnajc5
DnaJ heat shock protein family (Hsp40) member C5
decreases expression
EXP
Phlorhizin results in decreased expression of DNAJC5 mRNA
CTD
PMID:22538082
NCBI chr 2:181,162,141...181,194,679
Ensembl chr 2:181,162,278...181,196,926
G
Echs1
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial
decreases expression
EXP
Phlorhizin results in decreased expression of ECHS1 mRNA
CTD
PMID:22538082
NCBI chr 7:139,685,623...139,696,334
Ensembl chr 7:139,685,623...139,696,389
G
Ep300
E1A binding protein p300
decreases expression
EXP
Phlorhizin results in decreased expression of EP300 mRNA
CTD
PMID:22538082
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Ephx1
epoxide hydrolase 1, microsomal
decreases expression
EXP
Phlorhizin results in decreased expression of EPHX1 mRNA
CTD
PMID:22538082
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Fas
Fas cell surface death receptor
decreases expression
EXP
Phlorhizin results in decreased expression of FAS mRNA
CTD
PMID:16123366
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fbxw7
F-box and WD-40 domain protein 7
decreases expression
EXP
Phlorhizin results in decreased expression of FBXW7 mRNA
CTD
PMID:22538082
NCBI chr 3:84,721,901...84,886,505
Ensembl chr 3:84,722,575...84,886,505
G
Fh1
fumarate hydratase 1
decreases expression
EXP
Phlorhizin results in decreased expression of FH mRNA
CTD
PMID:22538082
NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201
G
Fis1
fission, mitochondrial 1
increases expression
EXP
Phlorhizin results in increased expression of FIS1 mRNA
CTD
PMID:22538082
NCBI chr 5:136,982,129...136,995,088
Ensembl chr 5:136,982,129...136,995,088
G
Fkbp5
FK506 binding protein 5
decreases expression
EXP
Phlorhizin results in decreased expression of FKBP5 mRNA
CTD
PMID:22538082
NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
G
Fmo1
flavin containing monooxygenase 1
decreases expression
EXP
Phlorhizin results in decreased expression of FMO1 mRNA
CTD
PMID:22538082
NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
multiple interactions
ISO
Phlorhizin inhibits the reaction [Streptozocin results in increased expression of G6PC1 mRNA]
CTD
PMID:12446591
NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression
EXP
Phlorhizin results in decreased expression of GCLC mRNA
CTD
PMID:22538082
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gclm
glutamate-cysteine ligase, modifier subunit
decreases expression
EXP
Phlorhizin results in decreased expression of GCLM mRNA
CTD
PMID:22538082
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Glrx2
glutaredoxin 2
decreases expression
EXP
Phlorhizin results in decreased expression of GLRX2 mRNA
CTD
PMID:22538082
NCBI chr 1:143,614,787...143,625,416
Ensembl chr 1:143,592,076...143,625,414
G
Gpd2
glycerol phosphate dehydrogenase 2, mitochondrial
increases expression decreases expression
EXP
Phlorhizin results in increased expression of GPD2 mRNA Phlorhizin results in decreased expression of GPD2 mRNA
CTD
PMID:16123366 PMID:22538082
NCBI chr 2:57,127,690...57,260,731
Ensembl chr 2:57,127,647...57,260,731
G
Gpx1
glutathione peroxidase 1
decreases expression
EXP
Phlorhizin results in decreased expression of GPX1 mRNA
CTD
PMID:16123366
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gpx7
glutathione peroxidase 7
increases expression
EXP
Phlorhizin results in increased expression of GPX7 mRNA
CTD
PMID:22538082
NCBI chr 4:108,257,414...108,263,910
Ensembl chr 4:108,257,587...108,264,158
G
Gsta1
glutathione S-transferase, alpha 1 (Ya)
decreases expression
EXP
Phlorhizin results in decreased expression of GSTA5 mRNA
CTD
PMID:22538082
NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966
G
Gstk1
glutathione S-transferase kappa 1
decreases expression
EXP
Phlorhizin results in decreased expression of GSTK1 mRNA
CTD
PMID:22538082
NCBI chr 6:42,222,869...42,227,375
Ensembl chr 6:42,222,869...42,227,381
G
Gstm1
glutathione S-transferase, mu 1
decreases expression
EXP
Phlorhizin results in decreased expression of GSTM1 mRNA
CTD
PMID:22538082
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstm2
glutathione S-transferase, mu 2
increases expression decreases expression
EXP
Phlorhizin results in increased expression of GSTM2 mRNA; Phlorhizin results in increased expression of GSTM5 mRNA Phlorhizin results in decreased expression of GSTM5 mRNA
CTD
PMID:22538082
NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
G
Gstm4
glutathione S-transferase, mu 4
increases expression
EXP
Phlorhizin results in increased expression of GSTM4 mRNA
CTD
PMID:22538082
NCBI chr 3:107,937,887...107,952,495
Ensembl chr 3:107,947,724...107,952,210
G
Gstp1
glutathione S-transferase, pi 1
increases expression
EXP
Phlorhizin results in increased expression of GSTP1 mRNA
CTD
PMID:22538082
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Gstt1
glutathione S-transferase, theta 1
decreases expression increases expression
EXP
Phlorhizin results in decreased expression of GSTT1 mRNA Phlorhizin results in increased expression of GSTT1 mRNA
CTD
PMID:22538082
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Gstt2
glutathione S-transferase, theta 2
decreases expression
EXP
Phlorhizin results in decreased expression of GSTT2B mRNA
CTD
PMID:22538082
NCBI chr10:75,667,676...75,673,253
Ensembl chr10:75,666,948...75,673,258
G
Hacd3
3-hydroxyacyl-CoA dehydratase 3
decreases expression
EXP
Phlorhizin results in decreased expression of HACD3 mRNA
CTD
PMID:22538082
NCBI chr 9:64,894,265...64,929,014
Ensembl chr 9:64,894,265...64,928,975
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
increases expression
EXP
Phlorhizin results in increased expression of HADHB mRNA
CTD
PMID:22538082
NCBI chr 5:30,360,251...30,389,591
Ensembl chr 5:30,360,246...30,389,591
G
Herpud1
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
decreases expression
EXP
Phlorhizin results in decreased expression of HERPUD1 mRNA
CTD
PMID:22538082
NCBI chr 8:95,113,057...95,121,999
Ensembl chr 8:95,113,066...95,122,005
G
Hibadh
3-hydroxyisobutyrate dehydrogenase
decreases expression
EXP
Phlorhizin results in decreased expression of HIBADH mRNA
CTD
PMID:22538082
NCBI chr 6:52,523,215...52,617,285
Ensembl chr 6:52,523,213...52,617,374
G
Hmgcs1
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
decreases expression
EXP
Phlorhizin results in decreased expression of HMGCS1 mRNA
CTD
PMID:22538082
NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796
G
Hmox1
heme oxygenase 1
decreases expression
EXP
Phlorhizin results in decreased expression of HMOX1 mRNA
CTD
PMID:16123366
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hras
Harvey rat sarcoma virus oncogene
increases expression
EXP
Phlorhizin results in increased expression of HRAS mRNA
CTD
PMID:22538082
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
decreases expression
EXP
Phlorhizin results in decreased expression of HSD17B10 mRNA
CTD
PMID:22538082
NCBI chr X:150,784,892...150,787,438
Ensembl chr X:150,784,841...150,787,438
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
decreases expression
EXP
Phlorhizin results in decreased expression of HSD17B4 mRNA
CTD
PMID:22538082
NCBI chr18:50,261,268...50,329,337
Ensembl chr18:50,261,268...50,329,336
G
Hsp90aa1
heat shock protein 90, alpha (cytosolic), class A member 1
decreases expression
EXP
Phlorhizin results in decreased expression of HSP90AA1 mRNA
CTD
PMID:22538082
NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
G
Hsp90ab1
heat shock protein 90 alpha (cytosolic), class B member 1
decreases expression
EXP
Phlorhizin results in decreased expression of HSP90AB1 mRNA
CTD
PMID:22538082
NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197
G
Hspa13
heat shock protein 70 family, member 13
decreases expression
EXP
Phlorhizin results in decreased expression of HSPA13 mRNA
CTD
PMID:22538082
NCBI chr16:75,552,078...75,564,575
Ensembl chr16:75,542,319...75,563,992
G
Hspa5
heat shock protein 5
increases expression
EXP
Phlorhizin results in increased expression of HSPA5 mRNA
CTD
PMID:22538082
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Hspa8
heat shock protein 8
increases expression
EXP
Phlorhizin results in increased expression of HSPA8 mRNA
CTD
PMID:22538082
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Hspa9
heat shock protein 9
decreases expression
EXP
Phlorhizin results in decreased expression of HSPA9 mRNA
CTD
PMID:22538082
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
G
Hspb1
heat shock protein 1
increases expression
EXP
Phlorhizin results in increased expression of HSPB1 mRNA
CTD
PMID:22538082
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
G
Hspb8
heat shock protein 8
decreases expression
EXP
Phlorhizin results in decreased expression of HSPB8 mRNA
CTD
PMID:22538082
NCBI chr 5:116,546,550...116,560,923
Ensembl chr 5:116,546,550...116,560,923
G
Hspd1
heat shock protein 1 (chaperonin)
decreases expression
EXP
Phlorhizin results in decreased expression of HSPD1 mRNA
CTD
PMID:22538082
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
G
Hspe1
heat shock protein 1 (chaperonin 10)
decreases expression
EXP
Phlorhizin results in decreased expression of HSPE1 mRNA
CTD
PMID:22538082
NCBI chr 1:55,127,307...55,130,476
Ensembl chr 1:55,127,291...55,130,466
G
Htra2
HtrA serine peptidase 2
decreases expression
EXP
Phlorhizin results in decreased expression of HTRA2 mRNA
CTD
PMID:22538082
NCBI chr 6:83,028,247...83,031,552
Ensembl chr 6:83,028,247...83,032,254
G
Id1
inhibitor of DNA binding 1, HLH protein
decreases expression
EXP
Phlorhizin results in decreased expression of ID1 mRNA
CTD
PMID:16123366
NCBI chr 2:152,578,171...152,579,330
Ensembl chr 2:152,578,171...152,579,330
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
increases expression
EXP
Phlorhizin results in increased expression of IDH2 mRNA
CTD
PMID:22538082
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Idh3a
isocitrate dehydrogenase 3 (NAD+) alpha
decreases expression
EXP
Phlorhizin results in decreased expression of IDH3A mRNA
CTD
PMID:22538082
NCBI chr 9:54,493,795...54,511,946
Ensembl chr 9:54,493,618...54,511,945
G
Idh3b
isocitrate dehydrogenase 3 (NAD+) beta
decreases expression
EXP
Phlorhizin results in decreased expression of IDH3B mRNA
CTD
PMID:22538082
NCBI chr 2:130,121,229...130,126,371
Ensembl chr 2:130,121,229...130,126,467
G
Idh3g
isocitrate dehydrogenase 3 (NAD+), gamma
decreases expression
EXP
Phlorhizin results in decreased expression of IDH3G mRNA
CTD
PMID:22538082
NCBI chr X:72,822,569...72,830,471
Ensembl chr X:72,822,569...72,830,503
G
Il1b
interleukin 1 beta
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phlorhizin] affects the expression of IL1B mRNA]; [cobaltous chloride co-treated with Phlorhizin] affects the expression of IL1B mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] affects the expression of IL1B mRNA
CTD
PMID:32408695
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il6
interleukin 6
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phlorhizin] affects the expression of IL6 mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] affects the expression of IL6 mRNA]; [cobaltous chloride co-treated with Phlorhizin] affects the expression of IL6 mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] affects the expression of IL6 mRNA
CTD
PMID:32408695
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Ivd
isovaleryl coenzyme A dehydrogenase
decreases expression
EXP
Phlorhizin results in decreased expression of IVD mRNA
CTD
PMID:22538082
NCBI chr 2:118,692,475...118,713,388
Ensembl chr 2:118,692,435...118,713,390
G
Junb
jun B proto-oncogene
decreases expression
EXP
Phlorhizin results in decreased expression of JUNB mRNA
CTD
PMID:22538082
NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347
G
Jund
jun D proto-oncogene
increases expression
EXP
Phlorhizin results in increased expression of JUND mRNA
CTD
PMID:22538082
NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
G
Kcnj11
potassium inwardly rectifying channel, subfamily J, member 11
increases expression
EXP
Phlorhizin results in increased expression of KCNJ11 mRNA
CTD
PMID:16123366
NCBI chr 7:45,746,545...45,750,215
Ensembl chr 7:45,743,377...45,750,188
G
Keap1
kelch-like ECH-associated protein 1
increases expression
EXP
Phlorhizin results in increased expression of KEAP1 mRNA
CTD
PMID:22538082
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Kras
Kirsten rat sarcoma viral oncogene homolog
decreases expression
EXP
Phlorhizin results in decreased expression of KRAS mRNA
CTD
PMID:22538082
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
G
Lep
leptin
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phlorhizin] affects the expression of LEP mRNA]; [2,2-bis(4-glycidyloxyphenyl)propane co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] affects the expression of LEP mRNA; [cobaltous chloride co-treated with Phlorhizin] affects the expression of LEP mRNA
CTD
PMID:32408695
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Maf
MAF bZIP transcription factor
decreases expression
EXP
Phlorhizin results in decreased expression of MAF mRNA
CTD
PMID:22538082
NCBI chr 8:116,429,992...116,433,633
Ensembl chr 8:116,409,681...116,434,533
G
Mafg
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian)
decreases expression
EXP
Phlorhizin results in decreased expression of MAFG mRNA
CTD
PMID:22538082
NCBI chr11:120,515,943...120,525,771
Ensembl chr11:120,515,943...120,524,426
G
Maob
monoamine oxidase B
decreases expression
EXP
Phlorhizin results in decreased expression of MAOB mRNA
CTD
PMID:22538082
NCBI chr X:16,575,520...16,683,605
Ensembl chr X:16,575,521...16,683,605
G
Map2k2
mitogen-activated protein kinase kinase 2
increases expression
EXP
Phlorhizin results in increased expression of MAP2K2 mRNA
CTD
PMID:22538082
NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809
G
Map2k6
mitogen-activated protein kinase kinase 6
increases expression
EXP
Phlorhizin results in increased expression of MAP2K6 mRNA
CTD
PMID:22538082
NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348
G
Map2k7
mitogen-activated protein kinase kinase 7
increases expression
EXP
Phlorhizin results in increased expression of MAP2K7 mRNA
CTD
PMID:22538082
NCBI chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897 Ensembl chr 8:4,288,740...4,297,897
G
Map3k7
mitogen-activated protein kinase kinase kinase 7
decreases expression
EXP
Phlorhizin results in decreased expression of MAP3K7 mRNA
CTD
PMID:22538082
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
G
Mapk3
mitogen-activated protein kinase 3
increases expression
EXP
Phlorhizin results in increased expression of MAPK3 mRNA
CTD
PMID:22538082
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk9
mitogen-activated protein kinase 9
decreases expression
EXP
Phlorhizin results in decreased expression of MAPK9 mRNA
CTD
PMID:22538082
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
G
Mccc2
methylcrotonoyl-Coenzyme A carboxylase 2 (beta)
decreases expression
EXP
Phlorhizin results in decreased expression of MCCC2 mRNA
CTD
PMID:22538082
NCBI chr13:100,085,040...100,152,147
Ensembl chr13:100,085,038...100,152,147
G
Mdm2
transformed mouse 3T3 cell double minute 2
decreases expression
EXP
Phlorhizin results in decreased expression of MDM2 mRNA
CTD
PMID:22538082
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Med20
mediator complex subunit 20
decreases expression
EXP
Phlorhizin results in decreased expression of MED20 mRNA
CTD
PMID:22538082
NCBI chr17:47,922,510...47,935,176
Ensembl chr17:47,922,507...47,935,343
G
Mgst1
microsomal glutathione S-transferase 1
increases expression
EXP
Phlorhizin results in increased expression of MGST1 mRNA
CTD
PMID:22538082
NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753
G
Mmut
methylmalonyl-Coenzyme A mutase
decreases expression
EXP
Phlorhizin results in decreased expression of MMUT mRNA
CTD
PMID:22538082
NCBI chr17:41,245,576...41,272,880
Ensembl chr17:41,245,576...41,272,879
G
Myl9
myosin, light polypeptide 9, regulatory
decreases phosphorylation
ISO
Phlorhizin results in decreased phosphorylation of MYL9 protein
CTD
PMID:17272349
NCBI chr 2:156,617,373...156,623,578
Ensembl chr 2:156,617,340...156,623,578
G
Ndufa12
NADH:ubiquinone oxidoreductase subunit A12
increases expression
EXP
Phlorhizin results in increased expression of NDUFA12 mRNA
CTD
PMID:22538082
NCBI chr10:94,034,897...94,057,302
Ensembl chr10:94,034,582...94,057,305
G
Ndufa2
NADH:ubiquinone oxidoreductase subunit A2
increases expression
EXP
Phlorhizin results in increased expression of NDUFA2 mRNA
CTD
PMID:22538082
NCBI chr18:36,875,385...36,877,640
Ensembl chr18:36,875,385...36,877,610
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
decreases expression
EXP
Phlorhizin results in decreased expression of NDUFA3 mRNA
CTD
PMID:22538082
NCBI chr 7:3,620,372...3,623,162
Ensembl chr 7:3,620,372...3,623,326
G
Ndufa7
NADH:ubiquinone oxidoreductase subunit A7
increases expression
EXP
Phlorhizin results in increased expression of NDUFA7 mRNA
CTD
PMID:22538082
NCBI chr17:34,043,546...34,057,290
Ensembl chr17:34,043,546...34,057,291
G
Ndufab1
NADH:ubiquinone oxidoreductase subunit AB1
increases expression
EXP
Phlorhizin results in increased expression of NDUFAB1 mRNA
CTD
PMID:22538082
NCBI chr 7:121,686,038...121,701,071
Ensembl chr 7:121,684,626...121,701,109
G
Ndufaf1
NADH:ubiquinone oxidoreductase complex assembly factor 1
decreases expression
EXP
Phlorhizin results in decreased expression of NDUFAF1 mRNA
CTD
PMID:22538082
NCBI chr 2:119,485,927...119,493,302
Ensembl chr 2:119,485,927...119,493,308
G
Ndufb6
NADH:ubiquinone oxidoreductase subunit B6
decreases expression
EXP
Phlorhizin results in decreased expression of NDUFB6 mRNA
CTD
PMID:22538082
NCBI chr 4:40,270,591...40,279,421
Ensembl chr 4:40,270,591...40,279,421
G
Ndufs1
NADH:ubiquinone oxidoreductase core subunit S1
decreases expression
EXP
Phlorhizin results in decreased expression of NDUFS1 mRNA
CTD
PMID:22538082
NCBI chr 1:63,182,751...63,215,981
Ensembl chr 1:63,182,755...63,215,992
G
Ndufs4
NADH:ubiquinone oxidoreductase core subunit S4
decreases expression
EXP
Phlorhizin results in decreased expression of NDUFS4 mRNA
CTD
PMID:22538082
NCBI chr13:114,424,331...114,524,630
Ensembl chr13:114,424,331...114,524,794
G
Ndufs5
NADH:ubiquinone oxidoreductase core subunit S5
decreases expression
EXP
Phlorhizin results in decreased expression of NDUFS5 mRNA
CTD
PMID:22538082
NCBI chr 4:123,606,503...123,611,979
Ensembl chr 4:123,606,503...123,611,995
G
Ndufs8
NADH:ubiquinone oxidoreductase core subunit S8
increases expression
EXP
Phlorhizin results in increased expression of NDUFS8 mRNA
CTD
PMID:22538082
NCBI chr19:3,958,863...3,962,774
Ensembl chr19:3,958,863...3,962,774
G
Nedd4
neural precursor cell expressed, developmentally down-regulated 4
decreases expression
EXP
Phlorhizin results in decreased expression of NEDD4 mRNA
CTD
PMID:22538082
NCBI chr 9:72,569,613...72,657,133
Ensembl chr 9:72,569,628...72,657,134
G
Neurod1
neurogenic differentiation 1
increases expression
EXP
Phlorhizin results in increased expression of NEUROD1 mRNA
CTD
PMID:16123366
NCBI chr 2:79,282,981...79,286,980
Ensembl chr 2:79,282,865...79,287,095
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
decreases expression
EXP
Phlorhizin results in decreased expression of NFE2L2 mRNA
CTD
PMID:22538082
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
multiple interactions
EXP
[Phlorhizin co-treated with 2,2-bis(4-glycidyloxyphenyl)propane co-treated with cobaltous chloride] affects the expression of NFKB1 mRNA
CTD
PMID:32408695
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nkx6-1
NK6 homeobox 1
increases expression
EXP
Phlorhizin results in increased expression of NKX6-1 mRNA
CTD
PMID:16123366
NCBI chr 5:101,807,050...101,812,577
Ensembl chr 5:101,806,005...101,812,862
G
Nos3
nitric oxide synthase 3, endothelial cell
multiple interactions decreases expression
ISO
Phlorhizin inhibits the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] Phlorhizin results in decreased expression of NOS3 mRNA
CTD
PMID:20021702
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nras
neuroblastoma ras oncogene
decreases expression
EXP
Phlorhizin results in decreased expression of NRAS mRNA
CTD
PMID:22538082
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
G
Ogdh
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)
decreases expression
EXP
Phlorhizin results in decreased expression of OGDH mRNA
CTD
PMID:22538082
NCBI chr11:6,241,597...6,309,094
Ensembl chr11:6,241,633...6,306,642
G
Park7
Parkinson disease (autosomal recessive, early onset) 7
increases expression
EXP
Phlorhizin results in increased expression of PARK7 mRNA
CTD
PMID:22538082
NCBI chr 4:150,981,590...150,994,378
Ensembl chr 4:150,981,590...150,998,894
G
Pcca
propionyl-Coenzyme A carboxylase, alpha polypeptide
decreases expression
EXP
Phlorhizin results in decreased expression of PCCA mRNA
CTD
PMID:22538082
NCBI chr14:122,721,822...123,127,372
Ensembl chr14:122,771,736...123,128,512
G
Pck1
phosphoenolpyruvate carboxykinase 1, cytosolic
decreases expression
EXP
Phlorhizin results in decreased expression of PCK1 mRNA
CTD
PMID:22538082
NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
G
Pcx
pyruvate carboxylase
increases expression decreases expression
EXP
Phlorhizin results in increased expression of PCX mRNA Phlorhizin results in decreased expression of PC mRNA
CTD
PMID:16123366 PMID:22538082
NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
G
Pecr
peroxisomal trans-2-enoyl-CoA reductase
increases expression decreases expression
EXP
Phlorhizin results in increased expression of PECR mRNA Phlorhizin results in decreased expression of PECR mRNA
CTD
PMID:22538082
NCBI chr 1:72,298,331...72,323,480
Ensembl chr 1:72,298,326...72,323,473
G
Pik3c2a
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha
decreases expression
EXP
Phlorhizin results in decreased expression of PIK3C2A mRNA
CTD
PMID:22538082
NCBI chr 7:115,936,500...116,042,693
Ensembl chr 7:115,936,500...116,042,684
G
Pik3c3
phosphatidylinositol 3-kinase catalytic subunit type 3
decreases expression
EXP
Phlorhizin results in decreased expression of PIK3C3 mRNA
CTD
PMID:22538082
NCBI chr18:30,390,441...30,481,179
Ensembl chr18:30,405,800...30,481,179
G
Pink1
PTEN induced putative kinase 1
increases expression
EXP
Phlorhizin results in increased expression of PINK1 mRNA
CTD
PMID:22538082
NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618
G
Prdx1
peroxiredoxin 1
increases expression
EXP
Phlorhizin results in increased expression of PRDX1 mRNA
CTD
PMID:22538082
NCBI chr 4:116,542,796...116,557,196
Ensembl chr 4:116,542,741...116,558,019
G
Prdx5
peroxiredoxin 5
decreases expression
EXP
Phlorhizin results in decreased expression of PRDX5 mRNA
CTD
PMID:22538082
NCBI chr19:6,884,065...6,887,474
Ensembl chr19:6,884,065...6,887,474
G
Prkch
protein kinase C, eta
increases expression
EXP
Phlorhizin results in increased expression of PRKCH mRNA
CTD
PMID:22538082
NCBI chr12:73,631,570...73,824,959
Ensembl chr12:73,631,570...73,824,959
G
Prkci
protein kinase C, iota
decreases expression
EXP
Phlorhizin results in decreased expression of PRKCI mRNA
CTD
PMID:22538082
NCBI chr 3:31,049,893...31,106,889
Ensembl chr 3:31,049,896...31,107,108
G
Prkd3
protein kinase D3
decreases expression
EXP
Phlorhizin results in decreased expression of PRKD3 mRNA
CTD
PMID:22538082
NCBI chr17:79,256,834...79,328,245
Ensembl chr17:79,256,834...79,328,245
G
Psma4
proteasome subunit alpha 4
decreases expression
EXP
Phlorhizin results in decreased expression of PSMA4 mRNA
CTD
PMID:22538082
NCBI chr 9:54,858,074...54,865,316
Ensembl chr 9:54,858,074...54,865,314
G
Psmb1
proteasome (prosome, macropain) subunit, beta type 1
increases expression
EXP
Phlorhizin results in increased expression of PSMB1 mRNA
CTD
PMID:22538082
NCBI chr17:15,695,983...15,718,538
Ensembl chr17:15,695,283...15,720,013
G
Psmb2
proteasome (prosome, macropain) subunit, beta type 2
decreases expression
EXP
Phlorhizin results in decreased expression of PSMB2 mRNA
CTD
PMID:22538082
NCBI chr 4:126,571,460...126,603,503
Ensembl chr 4:126,571,423...126,603,507
G
Psmc1
protease (prosome, macropain) 26S subunit, ATPase 1
decreases expression
EXP
Phlorhizin results in decreased expression of PSMC1 mRNA
CTD
PMID:22538082
NCBI chr12:100,076,461...100,089,623
Ensembl chr12:100,076,413...100,089,664
G
Psmc4
proteasome (prosome, macropain) 26S subunit, ATPase, 4
increases expression decreases expression
EXP
Phlorhizin results in increased expression of PSMC4 mRNA Phlorhizin results in decreased expression of PSMC4 mRNA
CTD
PMID:22538082
NCBI chr 7:27,741,127...27,749,517
Ensembl chr 7:27,741,132...27,749,526
G
Psmc6
proteasome (prosome, macropain) 26S subunit, ATPase, 6
decreases expression
EXP
Phlorhizin results in decreased expression of PSMC6 mRNA
CTD
PMID:22538082
NCBI chr14:45,567,285...45,587,150
Ensembl chr14:45,567,245...45,587,162
G
Psmd10
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
decreases expression
EXP
Phlorhizin results in decreased expression of PSMD10 mRNA
CTD
PMID:22538082
NCBI chr X:139,849,174...139,857,460
Ensembl chr X:139,849,178...139,857,477
G
Psmd12
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12
decreases expression
EXP
Phlorhizin results in decreased expression of PSMD12 mRNA
CTD
PMID:22538082
NCBI chr11:107,370,354...107,388,862
Ensembl chr11:107,370,310...107,395,188
G
Psmd14
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14
decreases expression
EXP
Phlorhizin results in decreased expression of PSMD14 mRNA
CTD
PMID:22538082
NCBI chr 2:61,542,038...61,630,720
Ensembl chr 2:61,542,038...61,630,720
G
Psmd4
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
decreases expression
EXP
Phlorhizin results in decreased expression of PSMD4 mRNA
CTD
PMID:22538082
NCBI chr 3:94,939,999...94,949,880
Ensembl chr 3:94,940,005...94,949,925
G
Psmd6
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6
increases expression
EXP
Phlorhizin results in increased expression of PSMD6 mRNA
CTD
PMID:22538082
NCBI chr14:8,348,818...8,357,578
Ensembl chr14:8,348,779...8,357,589
G
Psmd7
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7
decreases expression
EXP
Phlorhizin results in decreased expression of PSMD7 mRNA
CTD
PMID:22538082
NCBI chr 8:108,307,012...108,315,114
Ensembl chr 8:108,307,013...108,315,096
G
Psmd9
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
decreases expression
EXP
Phlorhizin results in decreased expression of PSMD9 mRNA
CTD
PMID:22538082
NCBI chr 5:123,366,253...123,388,189
Ensembl chr 5:123,307,476...123,388,194
G
Raf1
v-raf-leukemia viral oncogene 1
decreases expression
EXP
Phlorhizin results in decreased expression of RAF1 mRNA
CTD
PMID:22538082
NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
G
Rdh14
retinol dehydrogenase 14 (all-trans and 9-cis)
increases expression
EXP
Phlorhizin results in increased expression of RDH14 mRNA
CTD
PMID:22538082
NCBI chr12:10,440,752...10,445,562
Ensembl chr12:10,440,772...10,445,562
G
S100a6
S100 calcium binding protein A6 (calcyclin)
decreases expression
EXP
Phlorhizin results in decreased expression of S100A6 mRNA
CTD
PMID:16123366
NCBI chr 3:90,520,491...90,531,797
Ensembl chr 3:90,520,189...90,531,488
G
Sdha
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
decreases expression
EXP
Phlorhizin results in decreased expression of SDHA mRNA
CTD
PMID:22538082
NCBI chr13:74,470,374...74,498,359
Ensembl chr13:74,470,373...74,498,399
G
Sdhb
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
increases expression
EXP
Phlorhizin results in increased expression of SDHB mRNA
CTD
PMID:22538082
NCBI chr 4:140,688,582...140,706,509
Ensembl chr 4:140,688,514...140,706,504
G
Sds
serine dehydratase
decreases expression
EXP
Phlorhizin results in decreased expression of SDS mRNA
CTD
PMID:22538082
NCBI chr 5:120,614,612...120,621,997
Ensembl chr 5:120,614,591...120,621,997
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
increases expression
EXP
Phlorhizin results in increased expression of SLC2A2 mRNA
CTD
PMID:16123366
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
G
Slc35a2
solute carrier family 35 (UDP-galactose transporter), member A2
increases expression
EXP
Phlorhizin results in increased expression of SLC35A2 mRNA
CTD
PMID:22538082
NCBI chr X:7,750,189...7,760,699
Ensembl chr X:7,750,267...7,760,731
G
Slc5a1
solute carrier family 5 (sodium/glucose cotransporter), member 1
multiple interactions decreases activity affects binding
ISO EXP
Phlorhizin inhibits the reaction [[Sodium co-treated with SLC5A1 protein] results in increased uptake of methylglucoside]; Phlorhizin inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside] [Phlorhizin results in decreased activity of SLC5A1 protein] which results in decreased uptake of spiraeoside [Phlorhizin results in decreased activity of SLC5A1 protein] which results in decreased uptake of Glucose SLC5A1 protein binds to Phlorhizin
CTD
PMID:12663055 PMID:12927799 PMID:16300400 PMID:17288452 PMID:17983207
NCBI chr 5:33,261,563...33,320,043
Ensembl chr 5:33,261,563...33,320,214
G
Slc5a2
solute carrier family 5 (sodium/glucose cotransporter), member 2
decreases activity
ISO
Phlorhizin results in decreased activity of SLC5A2 protein
CTD
PMID:21128592
NCBI chr 7:127,864,855...127,871,602
Ensembl chr 7:127,864,829...127,871,602
G
Sod1
superoxide dismutase 1, soluble
increases expression
EXP
Phlorhizin results in increased expression of SOD1 mRNA
CTD
PMID:22538082
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
decreases expression
EXP
Phlorhizin results in decreased expression of SOD2 mRNA
CTD
PMID:22538082
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Stip1
stress-induced phosphoprotein 1
decreases expression
EXP
Phlorhizin results in decreased expression of STIP1 mRNA
CTD
PMID:22538082
NCBI chr19:6,998,064...7,017,394
Ensembl chr19:6,998,070...7,017,335
G
Sucla2
succinate-Coenzyme A ligase, ADP-forming, beta subunit
decreases expression
EXP
Phlorhizin results in decreased expression of SUCLA2 mRNA
CTD
PMID:22538082
NCBI chr14:73,790,226...73,833,584
Ensembl chr14:73,762,759...73,833,582
G
Suclg2
succinate-Coenzyme A ligase, GDP-forming, beta subunit
decreases expression
EXP
Phlorhizin results in decreased expression of SUCLG2 mRNA
CTD
PMID:22538082
NCBI chr 6:95,449,992...95,695,799
Ensembl chr 6:95,449,990...95,695,781
G
Sugt1
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
decreases expression
EXP
Phlorhizin results in decreased expression of SUGT1 mRNA
CTD
PMID:22538082
NCBI chr14:79,825,100...79,868,237
Ensembl chr14:79,825,131...79,872,636
G
Txn1
thioredoxin 1
decreases expression increases expression
EXP
Phlorhizin results in decreased expression of TXN mRNA Phlorhizin results in increased expression of TXN mRNA
CTD
PMID:22538082
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
G
Txn2
thioredoxin 2
increases expression
EXP
Phlorhizin results in increased expression of TXN2 mRNA
CTD
PMID:22538082
NCBI chr15:77,799,251...77,813,194
Ensembl chr15:77,799,247...77,813,206
G
Ubb
ubiquitin B
increases expression
EXP
Phlorhizin results in increased expression of UBB mRNA
CTD
PMID:22538082
NCBI chr11:62,442,329...62,444,037
Ensembl chr11:62,441,997...62,444,039
G
Ubc
ubiquitin C
decreases expression
EXP
Phlorhizin results in decreased expression of UBC mRNA
CTD
PMID:22538082
NCBI chr 5:125,463,029...125,467,081
Ensembl chr 5:125,463,029...125,467,266
G
Ube2b
ubiquitin-conjugating enzyme E2B
decreases expression
EXP
Phlorhizin results in decreased expression of UBE2B mRNA
CTD
PMID:22538082
NCBI chr11:51,875,965...51,894,972
Ensembl chr11:51,876,324...51,891,589
G
Ube2f
ubiquitin-conjugating enzyme E2F (putative)
decreases expression
EXP
Phlorhizin results in decreased expression of UBE2F mRNA
CTD
PMID:22538082
NCBI chr 1:91,177,412...91,214,243
Ensembl chr 1:91,178,026...91,218,059
G
Ube2h
ubiquitin-conjugating enzyme E2H
decreases expression
EXP
Phlorhizin results in decreased expression of UBE2H mRNA
CTD
PMID:22538082
NCBI chr 6:30,211,288...30,304,538
Ensembl chr 6:30,211,288...30,304,538
G
Ube2i
ubiquitin-conjugating enzyme E2I
decreases expression
EXP
Phlorhizin results in decreased expression of UBE2I mRNA
CTD
PMID:22538082
NCBI chr17:25,479,484...25,494,965
Ensembl chr17:25,479,482...25,493,856
G
Ube2l3
ubiquitin-conjugating enzyme E2L 3
decreases expression
EXP
Phlorhizin results in decreased expression of UBE2L3 mRNA
CTD
PMID:22538082
NCBI chr16:16,969,879...17,019,363
Ensembl chr16:16,969,877...17,020,513
G
Ube2m
ubiquitin-conjugating enzyme E2M
increases expression
EXP
Phlorhizin results in increased expression of UBE2M mRNA
CTD
PMID:22538082
NCBI chr 7:12,769,047...12,772,202
Ensembl chr 7:12,769,047...12,772,202
G
Ube2n
ubiquitin-conjugating enzyme E2N
decreases expression
EXP
Phlorhizin results in decreased expression of UBE2N mRNA
CTD
PMID:22538082
NCBI chr10:95,351,024...95,381,520
Ensembl chr10:95,351,007...95,381,519
G
Ube2q1
ubiquitin-conjugating enzyme E2Q family member 1
increases expression
EXP
Phlorhizin results in increased expression of UBE2Q1 mRNA
CTD
PMID:22538082
NCBI chr 3:89,680,905...89,691,304
Ensembl chr 3:89,680,923...89,691,307
G
Ube2r2
ubiquitin-conjugating enzyme E2R 2
decreases expression
EXP
Phlorhizin results in decreased expression of UBE2R2 mRNA
CTD
PMID:22538082
NCBI chr 4:41,136,021...41,193,370
Ensembl chr 4:41,135,743...41,193,380
G
Ube2v2
ubiquitin-conjugating enzyme E2 variant 2
decreases expression
EXP
Phlorhizin results in decreased expression of UBE2V2 mRNA
CTD
PMID:22538082
NCBI chr16:15,368,850...15,412,382
Ensembl chr16:15,369,941...15,413,637
G
Ube4a
ubiquitination factor E4A
increases expression
EXP
Phlorhizin results in increased expression of UBE4A mRNA
CTD
PMID:22538082
NCBI chr 9:44,834,425...44,877,021
Ensembl chr 9:44,834,425...44,876,898
G
Ubr2
ubiquitin protein ligase E3 component n-recognin 2
increases expression
EXP
Phlorhizin results in increased expression of UBR2 mRNA
CTD
PMID:22538082
NCBI chr17:47,239,217...47,321,812
Ensembl chr17:47,239,221...47,321,482
G
Uchl3
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)
decreases expression
EXP
Phlorhizin results in decreased expression of UCHL3 mRNA
CTD
PMID:22538082
NCBI chr14:101,891,387...101,933,561
Ensembl chr14:101,891,403...101,933,561
G
Uchl5
ubiquitin carboxyl-terminal esterase L5
decreases expression
EXP
Phlorhizin results in decreased expression of UCHL5 mRNA
CTD
PMID:22538082
NCBI chr 1:143,652,993...143,683,204
Ensembl chr 1:143,653,010...143,683,204
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
decreases activity
ISO
Phlorhizin results in decreased activity of UGT1A1 protein
CTD
PMID:35868516
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Ugt1a10
UDP glycosyltransferase 1 family, polypeptide A10
decreases activity
ISO
Phlorhizin results in decreased activity of UGT1A10 protein
CTD
PMID:35868516
NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
decreases activity
ISO
Phlorhizin results in decreased activity of UGT1A3 protein
CTD
PMID:35868516
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
G
Ugt1a9
UDP glucuronosyltransferase 1 family, polypeptide A9
decreases activity
ISO
Phlorhizin results in decreased activity of UGT1A9 protein
CTD
PMID:35868516
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
decreases activity
ISO
Phlorhizin results in decreased activity of UGT2B17 protein
CTD
PMID:35868516
NCBI chr 5:87,064,498...87,074,362
Ensembl chr 5:87,064,497...87,074,389
G
Ugt2b34
UDP glucuronosyltransferase 2 family, polypeptide B34
decreases activity
ISO
Phlorhizin results in decreased activity of UGT2B7 protein
CTD
PMID:35868516
NCBI chr 5:87,037,613...87,054,805
Ensembl chr 5:87,037,626...87,054,796
G
Uqcrc2
ubiquinol cytochrome c reductase core protein 2
decreases expression
EXP
Phlorhizin results in decreased expression of UQCRC2 mRNA
CTD
PMID:22538082
NCBI chr 7:120,234,412...120,258,746
Ensembl chr 7:120,234,399...120,258,747
G
Usp1
ubiquitin specific peptidase 1
increases expression
EXP
Phlorhizin results in increased expression of USP1 mRNA
CTD
PMID:22538082
NCBI chr 4:98,812,047...98,823,780
Ensembl chr 4:98,812,047...98,823,780
G
Usp14
ubiquitin specific peptidase 14
decreases expression
EXP
Phlorhizin results in decreased expression of USP14 mRNA
CTD
PMID:22538082
NCBI chr18:9,993,615...10,030,149
Ensembl chr18:9,993,066...10,045,119
G
Usp19
ubiquitin specific peptidase 19
increases expression
EXP
Phlorhizin results in increased expression of USP19 mRNA
CTD
PMID:22538082
NCBI chr 9:108,367,806...108,379,536
Ensembl chr 9:108,367,801...108,379,536
G
Usp24
ubiquitin specific peptidase 24
decreases expression
EXP
Phlorhizin results in decreased expression of USP24 mRNA
CTD
PMID:22538082
NCBI chr 4:106,173,179...106,303,798
Ensembl chr 4:106,173,417...106,298,519
G
Usp33
ubiquitin specific peptidase 33
decreases expression
EXP
Phlorhizin results in decreased expression of USP33 mRNA
CTD
PMID:22538082
NCBI chr 3:152,051,797...152,099,254
Ensembl chr 3:152,052,115...152,099,254
G
Usp4
ubiquitin specific peptidase 4 (proto-oncogene)
increases expression
EXP
Phlorhizin results in increased expression of USP4 mRNA
CTD
PMID:22538082
NCBI chr 9:108,223,763...108,269,744
Ensembl chr 9:108,225,052...108,269,744
G
Usp45
ubiquitin specific petidase 45
decreases expression
EXP
Phlorhizin results in decreased expression of USP45 mRNA
CTD
PMID:22538082
NCBI chr 4:21,767,161...21,837,872
Ensembl chr 4:21,767,156...21,837,872
G
Usp46
ubiquitin specific peptidase 46
decreases expression
EXP
Phlorhizin results in decreased expression of USP46 mRNA
CTD
PMID:22538082
NCBI chr 5:74,159,387...74,229,070
Ensembl chr 5:74,159,114...74,229,092
G
Usp7
ubiquitin specific peptidase 7
decreases expression
EXP
Phlorhizin results in decreased expression of USP7 mRNA
CTD
PMID:22538082
NCBI chr16:8,506,586...8,574,931
Ensembl chr16:8,507,459...8,610,172
G
Usp9x
ubiquitin specific peptidase 9, X chromosome
decreases expression
EXP
Phlorhizin results in decreased expression of USP9X mRNA
CTD
PMID:22538082
NCBI chr X:12,937,221...13,039,567
Ensembl chr X:12,937,737...13,039,567
G
Vegfa
vascular endothelial growth factor A
multiple interactions
EXP
2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] results in increased expression of VEGFA mRNA]; 2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phlorhizin] affects the expression of VEGFA mRNA]; [cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phlorhizin] results in increased expression of VEGFA mRNA; [cobaltous chloride co-treated with Phlorhizin] affects the expression of VEGFA mRNA
CTD
PMID:32408695
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
EXP
Phlorhizin results in decreased expression of XIAP mRNA
CTD
PMID:22538082
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
G
Bax
BCL2-associated X protein
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide affects the localization of BAX protein]
CTD
PMID:30104959
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]
CTD
PMID:30104959
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Cat
catalase
multiple interactions
EXP
NFE2L2 protein affects the reaction [trilobatin inhibits the reaction [Isoflurane results in decreased activity of CAT protein]]; trilobatin inhibits the reaction [Isoflurane results in decreased activity of CAT protein]
CTD
PMID:32663520
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Esrra
estrogen related receptor, alpha
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ESRRA protein]
CTD
PMID:30104959
NCBI chr19:6,888,345...6,899,182
Ensembl chr19:6,888,345...6,899,208
G
Foxo3
forkhead box O3
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of FOXO3 protein]
CTD
PMID:30104959
NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of GPX1 protein]
CTD
PMID:30104959
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Hmox1
heme oxygenase 1
multiple interactions
EXP ISO
trilobatin promotes the reaction [Isoflurane results in increased expression of HMOX1 mRNA]; trilobatin promotes the reaction [Isoflurane results in increased expression of HMOX1 protein] trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of HMOX1 protein]
CTD
PMID:30104959 PMID:32663520
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased activity of IDH2 protein]; trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein]
CTD
PMID:30104959
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Il1b
interleukin 1 beta
multiple interactions
EXP
trilobatin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; trilobatin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
CTD
PMID:25053100
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il6
interleukin 6
multiple interactions
EXP
trilobatin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; trilobatin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; trilobatin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:25053100
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Keap1
kelch-like ECH-associated protein 1
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in increased expression of KEAP1 protein]
CTD
PMID:30104959
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
mt-Atp6
ATP synthase 6, mitochondrial
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP6 mRNA]
CTD
PMID:30104959
NCBI chr MT:7,927...8,607
Ensembl chr MT:7,927...8,607
G
mt-Co1
cytochrome c oxidase I, mitochondrial
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX1 mRNA]
CTD
PMID:30104959
NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
G
mt-Cytb
cytochrome b, mitochondrial
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of CYTB mRNA]
CTD
PMID:30104959
NCBI chr MT:14,145...15,288
Ensembl chr MT:14,145...15,288
G
mt-Nd2
NADH dehydrogenase 2, mitochondrial
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ND2 mRNA]
CTD
PMID:30104959
NCBI chr MT:3,914...4,951
Ensembl chr MT:3,914...4,951
G
mt-Nd5
NADH dehydrogenase 5, mitochondrial
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ND5 mRNA]
CTD
PMID:30104959
NCBI chr MT:11,742...13,565
Ensembl chr MT:11,742...13,565
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
multiple interactions
ISO EXP
trilobatin promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein] NFE2L2 protein affects the reaction [trilobatin inhibits the reaction [Isoflurane results in decreased activity of CAT protein]]; trilobatin promotes the reaction [Isoflurane results in increased expression of NFE2L2 protein]
CTD
PMID:30104959 PMID:32663520
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
multiple interactions
EXP
trilobatin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]
CTD
PMID:25053100
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
multiple interactions
EXP ISO
trilobatin promotes the reaction [Isoflurane results in increased expression of NQO1 mRNA]; trilobatin promotes the reaction [Isoflurane results in increased expression of NQO1 protein] trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of NQO1 protein]
CTD
PMID:30104959 PMID:32663520
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARGC1A protein]
CTD
PMID:30104959
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
EXP
trilobatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]
CTD
PMID:25053100
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Sirt3
sirtuin 3
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT3 mRNA]; trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT3 protein]
CTD
PMID:30104959
NCBI chr 7:140,443,576...140,462,222
Ensembl chr 7:140,443,579...140,462,222
G
Sod2
superoxide dismutase 2, mitochondrial
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased activity of SOD2 protein]; trilobatin inhibits the reaction [Hydrogen Peroxide results in increased acetylation of SOD2 protein]
CTD
PMID:30104959
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Tnf
tumor necrosis factor
multiple interactions
EXP
trilobatin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; trilobatin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; trilobatin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:25053100
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Ucp2
uncoupling protein 2 (mitochondrial, proton carrier)
multiple interactions
ISO
trilobatin inhibits the reaction [Hydrogen Peroxide results in increased expression of UCP2 protein]
CTD
PMID:30104959
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
22178
chemical entity
22208
atom
22170
nonmetal atom
22055
oxygen atom
21437
oxygen molecular entity
21409
flavonoids
11802
dihydrochalcones
754
1-(2-hydroxyphenyl)-3-phenylpropane-1,3-dione
0
1-(2H-1,3-benzodioxol-5-yl)-3-hydroxy-3-(4-methoxy-1-benzofuran-5-yl)propan-1-one
0
1-(3,4-dihydroxyphenyl)-3-(4-methoxy-1-benzofuran-5-yl)propane-1,3-dione
0
1-(4-hydroxy-3-methoxyphenyl)-3-(2-hydroxyphenyl)propan-1-one
0
2',4',6'-trihydroxy-3'-formyldihydrochalcone
0
2',4',beta-Trihydroxy-6'-methoxychalcone
0
2',6',beta-Trihydroxy-4'-methoxychalcone
0
2',6'-dihydroxy-4'-methoxydihydrochalcone
0
2'-O-methyllicodione
0
2'-O-methylodoratol
0
2,3-Dihydroxy-1,3-diphenyl-1-propanone
0
2,4'-Dihydroxy-4-methoxydihydrochalcone
0
2-Hydroxy-4,5,6-trimethoxydihydrochalcone
0
2-methoxy-4-hydroxydihydrochalcone
0
3'-(beta-D-glucopyranosyl)-2'-hydroxy-beta-oxodihydrochalcone
0
3-(4-methoxyphenyl)-3-(4-methylphenyl)sulfonyl-1-phenyl-1-propanone
0
3-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)-1-(4-hydroxyphenyl)propan-1-one
0
3-(benzenesulfonyl)-3-(4-methoxyphenyl)-1-phenyl-1-propanone
0
3-[2-(hydroxymethyl)-5-methoxy-2-methyl-2H-chromen-6-yl]-1-(4-hydroxyphenyl)propan-1-one
0
3-hydroxyphloretin 2'-O-xylosylglucoside
0
6-[1-(3,4-dihydroxyphenyl)-3-(4-methoxy-1-benzofuran-5-yl)-1,3-dioxopropan-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
0
6C-glucosyl-2-hydroxynaringenin
0
Brosimacutin I
0
Chamuvaritin
0
Glycyrdione B
0
Kanzonol A
0
Loureirin B
0
Loureirin C
0
Ovalitenone
0
[3-(3,4-dihydroxyphenyl)-3-oxo-1-phenylpropoxy]sulfonic acid
0
\{2-hydroxy-5-[3-(2-hydroxyphenyl)propanoyl]phenyl\}oxidanesulfonic acid
0
\{2-hydroxy-5-[3-(4-methoxy-1-benzofuran-5-yl)-3-oxopropanoyl]phenyl\}oxidanesulfonic acid
0
\{2-hydroxy-5-[3-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propanoyl]phenyl\}oxidanesulfonic acid
0
\{3-[3-(2-hydroxyphenyl)propanoyl]phenyl\}oxidanesulfonic acid
0
\{3-[3-(3,4-dihydroxyphenyl)-3-oxopropyl]phenyl\}oxidanesulfonic acid
0
acumitin
0
alkofanone
0
asebogenin
0
aspalathin
17
avobenzone
443
bipinnatone A
0
bipinnatone B
0
davidigenin
0
dihydrochalcone +
315
dihydroxanthohumol
0
diuvaretin
0
isochamuvaritin
0
lespeflorin C3
0
licodione +
0
littorachalcone
0
neohesperidin dihydrochalcone
9
odoratol +
0
phloretin +
315
phlorizin
249
trilobatin
25
uvaretin
0
Path 2
CHEBI ontology
22178
subatomic particle
22170
composite particle
22170
hadron
22201
baryon
22170
nucleon
22170
atomic nucleus
22170
atom
22170
main group element atom
22104
p-block element atom
22104
carbon group element atom
21904
carbon atom
21859
organic molecular entity
21830
heteroorganic entity
21482
organochalcogen compound
20966
organooxygen compound
20806
carbonyl compound
20172
ketone
17949
aromatic ketone
12595
dihydrochalcones
754
1-(2-hydroxyphenyl)-3-phenylpropane-1,3-dione
0
1-(2H-1,3-benzodioxol-5-yl)-3-hydroxy-3-(4-methoxy-1-benzofuran-5-yl)propan-1-one
0
1-(3,4-dihydroxyphenyl)-3-(4-methoxy-1-benzofuran-5-yl)propane-1,3-dione
0
1-(4-hydroxy-3-methoxyphenyl)-3-(2-hydroxyphenyl)propan-1-one
0
2',4',6'-trihydroxy-3'-formyldihydrochalcone
0
2',4',beta-Trihydroxy-6'-methoxychalcone
0
2',6',beta-Trihydroxy-4'-methoxychalcone
0
2',6'-dihydroxy-4'-methoxydihydrochalcone
0
2'-O-methyllicodione
0
2'-O-methylodoratol
0
2,3-Dihydroxy-1,3-diphenyl-1-propanone
0
2,4'-Dihydroxy-4-methoxydihydrochalcone
0
2-Hydroxy-4,5,6-trimethoxydihydrochalcone
0
2-methoxy-4-hydroxydihydrochalcone
0
3'-(beta-D-glucopyranosyl)-2'-hydroxy-beta-oxodihydrochalcone
0
3-(4-methoxyphenyl)-3-(4-methylphenyl)sulfonyl-1-phenyl-1-propanone
0
3-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)-1-(4-hydroxyphenyl)propan-1-one
0
3-(benzenesulfonyl)-3-(4-methoxyphenyl)-1-phenyl-1-propanone
0
3-[2-(hydroxymethyl)-5-methoxy-2-methyl-2H-chromen-6-yl]-1-(4-hydroxyphenyl)propan-1-one
0
3-hydroxyphloretin 2'-O-xylosylglucoside
0
6-[1-(3,4-dihydroxyphenyl)-3-(4-methoxy-1-benzofuran-5-yl)-1,3-dioxopropan-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
0
6C-glucosyl-2-hydroxynaringenin
0
Brosimacutin I
0
Chamuvaritin
0
Glycyrdione B
0
Kanzonol A
0
Loureirin B
0
Loureirin C
0
Ovalitenone
0
[3-(3,4-dihydroxyphenyl)-3-oxo-1-phenylpropoxy]sulfonic acid
0
\{2-hydroxy-5-[3-(2-hydroxyphenyl)propanoyl]phenyl\}oxidanesulfonic acid
0
\{2-hydroxy-5-[3-(4-methoxy-1-benzofuran-5-yl)-3-oxopropanoyl]phenyl\}oxidanesulfonic acid
0
\{2-hydroxy-5-[3-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propanoyl]phenyl\}oxidanesulfonic acid
0
\{3-[3-(2-hydroxyphenyl)propanoyl]phenyl\}oxidanesulfonic acid
0
\{3-[3-(3,4-dihydroxyphenyl)-3-oxopropyl]phenyl\}oxidanesulfonic acid
0
acumitin
0
alkofanone
0
asebogenin
0
aspalathin
17
avobenzone
443
bipinnatone A
0
bipinnatone B
0
davidigenin
0
dihydrochalcone +
315
dihydroxanthohumol
0
diuvaretin
0
isochamuvaritin
0
lespeflorin C3
0
licodione +
0
littorachalcone
0
neohesperidin dihydrochalcone
9
odoratol +
0
phloretin +
315
phlorizin
249
trilobatin
25
uvaretin
0